Puerto Rico
|
|
66-0555678
|
(STATE OF INCORPORATION)
|
|
(I.R.S. ID)
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
Class B common stock, $1.00 par value
|
GTS
|
New York Stock Exchange
|
Large accelerated filer ☑
|
Accelerated filer ☐
|
Non-accelerated filer ☐
|
Smaller reporting company ☐
|
|
Emerging growth company ☐
|
3
|
|
Item 1. Business
|
3
|
Item 1A. Risk Factors
|
29
|
Item 1B. Unresolved Staff Comments
|
50
|
Item 2. Properties
|
50
|
Item 3. Legal Proceedings
|
51
|
Item 4. Mine Safety Disclosures
|
51
|
51
|
|
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
51
|
Item 6. Selected Financial Data
|
54
|
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
55
|
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
|
83
|
Item 8. Financial Statements and Supplementary Data
|
86
|
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures
|
88
|
Item 9A. Controls and Procedures
|
89
|
9B. Other Information
|
90
|
91
|
|
Item 10. Directors, Executive Officers and Corporate Governance
|
91
|
Item 11. Executive Compensation
|
91
|
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
91
|
Item 13. Certain Relationships and Related Transactions, and Director Independence
|
91
|
Item 14. Principal Accountant Fees and Services
|
91
|
92
|
|
Item 15. Exhibits and Financial Statements Schedules
|
92
|
Item 16. Form 10-K Summay
|
93
|
97
|
Market Sector
|
Enrollment at
December 31, 2019
|
Percentage of
Total Enrollment
|
||||||
Commercial
|
440,669
|
47.7
|
%
|
|||||
Medicare
|
127,789
|
13.8
|
%
|
|||||
Medicaid
|
355,465
|
38.5
|
%
|
|||||
Total
|
923,923
|
100.0
|
%
|
• |
failure to maintain our total adjusted capital at or above 375% of Health Risk-Based Capital (“HRBC”) Authorized Control Level (“ACL”) as defined by the National Association of Insurance Commissioners (“NAIC”) for the for Primary Licensee (TSM) and Larger BCBS Controlled Affiliate (TSS) and 100% HRBC ACL for the Smaller BCBS Controlled Affiliate (TSA);
|
• |
failure to maintain liquidity of greater than one month of underwritten claims and administrative expenses, as defined by the BCBSA, for two consecutive quarters;
|
• |
failure to satisfy state-mandated statutory net worth requirements;
|
• |
impending financial insolvency; and
|
• |
a change of control not otherwise approved by the BCBSA or a violation of the BCBSA voting and ownership limitations on our capital stock.
|
• |
grant, suspend and revoke licenses to transact business;
|
• |
regulate many aspects of the products and services we offer, including the review and approval of health insurance rates in the individual and small group markets;
|
• |
assess fines, penalties and/or sanctions;
|
• |
monitor our solvency and the adequacy of our financial reserves; and
|
• |
regulate our investment activities based on quality, diversification and other quantitative criteria, within the parameters of a list of permitted investments set forth in the insurance laws and regulations.
|
• |
initiatives to provide greater access to coverage for uninsured and under-insured populations without adequate funding to health plans or to be funded through taxes or other negative financial levies on health plans;
|
• |
other efforts or specific legislative changes to the Medicare or Medicaid program, including changes in the bidding process or other means that materially reduce premiums;
|
• |
local government regulatory changes;
|
• |
increased government enforcement, or changes in interpretation or application of fraud and abuse laws; and
|
• |
regulations that increase the operational burden on health plans or laws that increase a health plan’s exposure to liabilities, including efforts to expand the tort liability of health care plans.
|
• |
Part A covers, among other things, inpatient hospital stays, skilled nursing facility stays, home health visits (also covered under Part B), and hospice care. Individuals are automatically enrolled in Part A and inpatient hospital stays are subject to an annual deductible.
|
• |
Part B covers physician visits, outpatient services, laboratory services, durable medical equipment, certain preventive services, and home health visits. Enrollment in Part B is voluntary and subject to an annual deductible and monthly premiums.
|
• |
Part C, which encompasses Medicare Advantage in addition to other supplemental plans, allows beneficiaries to enroll in private health plans and receive Medicare-covered benefits.
|
o |
Medicare Advantage. In 2019, one third of all Medicare beneficiaries—about 22 million—were enrolled in Medicare Advantage plans. The Congressional Budget Office projects that the share of Medicare beneficiaries enrolled in Medicare Advantage will rise to about 47 percent by 2029. Medicare Advantage plans are required to maintain a medical loss ratio (“MLR”) of at least 85%, meaning, very basically, that if Medicare Advantage plans do not spend at least 85% of their revenue on patient care costs, they may face various sanctions, including refunds, prohibition on enrolling new members, and contract termination. The Part C premium varies by plan.
|
o |
Other Medicare Supplemental Plans. “Medicap” is another type of private plan that fill sin the patient out-of-pocket gaps in traditional fee-for-service Medicare Part A and B coverage. These Medigap policies are standardize by CMS, but funded and administered by private organizations.
|
• |
Part D is the voluntary, subsidized outpatient prescription drug benefit created under the Medicare Modernization Act of 2003 (the “MMA”). Part D includes subsidies for beneficiaries with low incomes that do not apply to Puerto Rico. Part D is offered through private plans that contract with Medicare, including stand-alone prescription drug plans and Medicare Advantage prescription drug plans. Part D plans are also subject to MLR requirements and their premium varies by plan.
|
• |
trends in health care costs and utilization rates;
|
• |
ability to secure sufficient premium rate increases;
|
• |
competitor pricing below market trends of increasing costs;
|
• |
re-estimates of our policy and contract liabilities;
|
• |
changes in government laws and regulations of managed care, life insurance or property and casualty insurance;
|
• |
significant acquisitions or divestitures by major competitors;
|
• |
introduction and use of new prescription drugs and technologies;
|
• |
a downgrade in our financial strength ratings;
|
• |
litigation or legislation targeted at managed care, life insurance or property and casualty insurance companies;
|
• |
ability to contract with providers and government agencies consistent with past practice;
|
• |
ability to successfully implement our disease management and utilization management programs;
|
• |
ability to maintain Federal Employees, Medicare, and Medicaid contracts;
|
• |
volatility in the securities markets and investment losses and defaults; and
|
• |
general economic downturns, major disasters and epidemics.
|
• |
Commercial: One of our Managed Care subsidiaries is a qualified contractor to provide managed care coverage to federal government employees within Puerto Rico. Such coverage is provided pursuant to a contract with the OPM that is subject to termination in the event of non-compliance not corrected to the satisfaction of the OPM. During each of the years ended December 31, 2019, 2018, and 2017 premiums generated under this contract represented 5.3%, 5.5%, and 5.7% of our consolidated premiums earned, net, respectively.
|
• |
Medicare: We provide services through our Medicare Advantage products pursuant to a limited number of contracts with CMS. These contracts generally have terms of one year and must be renewed each year. Each of our contracts with CMS is cancellable for cause if we breach a material provision of the contract or violate relevant laws or regulations. If we are unable to renew, or to successfully re-bid or compete for any of these contracts, or if the process for bidding materially changes or if any of these contracts are terminated, our business could be materially impaired. During each of the years ended December 31, 2019, 2018, and 2017, contracts with CMS represented 43.3%, 38.5%, and 36.6% of our consolidated premiums earned, net, respectively.
|
• |
Medicaid: We participate in the government of Puerto Rico Health Reform Program (similar to Medicaid), known as Vital (“Vital”), to provide health coverage to medically indigent citizens in Puerto Rico. The current agreement, which became effective November 1, 2018, requires MCOs to serve subscribers on an island-wide basis, rather than assigning each MCO to specific regions, as under the previous model. The term of the agreement ends on September 30, 2021, which may be extended for an additional year at ASES’s option. Under the current agreement, TSS is responsible for providing medical, mental, pharmacy and dental healthcare services on an at-risk basis to subscribers who enroll with TSS. ASES pays TSS a per member per month rate that varies depending on the particular clinical condition or category of the subscriber. Premium rates will be negotiated for each contract year. Participants may change insurance carriers once every year. As of December 31, 2019 and 2018, our Medicaid membership was approximately 355,000 and 319,000 members, respectively. Under the previous agreement with ASES, we provided services to eligible members in the Metro North and West regions of Puerto Rico. During the years ended December 31, 2019, 2018 and 2017 Medicaid premiums generated through our agreements with ASES represented 26.5%, 26.4% and 26.6%, respectively.
|
• |
rising levels of actual costs that are not known by companies at the time they price their products;
|
• |
volatile and unpredictable developments, including man-made and natural catastrophes;
|
• |
changes in reserves resulting from the general claims and legal environments as different types of claims arise and judicial interpretations relating to the scope of insurers’ liability develop; and
|
• |
fluctuations in interest rates, inflationary pressures and other changes in the investment environment, which affect returns on invested capital.
|
• |
Significantly reducing the value of the debt and equity securities we hold in our investment portfolio, and creating net unrealized capital losses that reduce our operating results and/or net realized capital losses in the event we are required to sell some of those investments.
|
• |
Lowering interest rates on high quality short-term debt securities and thereby materially reducing our net investment income and operating results.
|
• |
Making it more difficult to value certain of our investment securities, for example if trading becomes less frequent, which could lead to significant period-to-period changes in our estimates of the fair values of those securities and cause period-to-period volatility in our operating results and shareholders’ equity.
|
• |
Reducing our ability to issue other securities.
|
• |
identify profitable growth opportunities in current and additional markets;
|
• |
transact successful acquisitions, capital investments and other growth initiatives;
|
• |
determine the correct value of assets and investments;
|
• |
implement adequate pricing and operational structure, including underwriting and claim management processes;
|
• |
design attractive and profitable insurance and health products and services;
|
• |
recruit required personnel for expanded operations, including officers, agents, brokers, medical providers, and other key personnel;
|
• |
obtain regulatory permission required to operate in other jurisdictions or lines of business;
|
• |
comply with regulatory requirements;
|
• |
integrate acquired business to our operations, including integration of information technology, management and personnel, and administrative systems;
|
• |
acquire business and regulatory knowledge and expertise in new lines of business;
|
• |
create the expected return over time; and
|
• |
implement new, or modify existing internal monitoring and control systems.
|
• |
initiatives to provide greater access to coverage for uninsured and under-insured populations without adequate funding to health plan or to be funded through taxes or other negative financial levy on health plans;
|
• |
payments to health plans that are tied to the achievement of certain quality performance measures and medical loss ratio requirements;
|
• |
specific legislative or regulatory changes to the Medicare or Medicaid programs, including changes in the bidding process or other means to materially reduce premiums;
|
• |
local government regulatory changes;
|
• |
increased government enforcement actions, or changes in the interpretation or application, of fraud and abuse and health information privacy laws; and
|
• |
regulations that increase the operational burden on health plans, or that increase a health plan’s exposure to liabilities, including efforts to expand the tort liability of health plans.
|
• |
recoupment of amounts we have been paid pursuant to our government contracts;
|
• |
mandated changes in our business practices;
|
• |
imposition of significant civil or criminal penalties, fines or other sanctions on us and/or our key employees;
|
• |
additional reporting requirements and oversight and mandated corrective action or remediation plans;
|
• |
loss or non-renewal of our government contracts or loss of our ability to participate in Medicare or other federal or local governmental payor programs;
|
• |
damage to our reputation;
|
• |
increased difficulty in marketing our products and services;
|
• |
inability to obtain approval for future services or geographic expansions;
|
• |
loss of one or more of our licenses to act as an insurance company, preferred provider or managed care organization or other licensed entity or to otherwise provide a service; and
|
• |
suspension of ability to subscribe members.
|
• |
permit our board of directors to issue one or more series of preferred stock;
|
• |
divide our board of directors into three classes serving staggered three-year terms;
|
• |
limit the ability of shareholders to remove directors;
|
• |
impose restrictions on shareholders’ ability to fill vacancies on our board of directors;
|
• |
impose advance notice requirements for shareholder proposals and nominations of directors to be considered at meetings of shareholders; and
|
• |
impose restrictions on shareholders’ ability to amend our articles and bylaws.
|
|
High
|
Low
|
||||||
2019
|
||||||||
First quarter
|
$
|
26.46
|
$
|
15.93
|
||||
Second quarter
|
26.51
|
19.42
|
||||||
Third quarter
|
27.64
|
13.10
|
||||||
Fourth quarter
|
20.25
|
12.66
|
||||||
2018
|
||||||||
First quarter
|
$
|
28.66
|
$
|
22.75
|
||||
Second quarter
|
44.01
|
25.65
|
||||||
Third quarter
|
40.44
|
18.65
|
||||||
Fourth quarter
|
22.16
|
15.45
|
Ticker
|
Name
|
1/2/2015
|
12/31/2015
|
12/30/2016
|
12/29/2017
|
12/31/2018
|
12/31/2019
|
GTS US Equity
|
TRIPLE-S MANAGEMENT CORP
|
100.00
|
124.47
|
107.76
|
129.36
|
90.53
|
101.17
|
SPX Index
|
S&P 500 INDEX
|
100.00
|
111.57
|
122.21
|
145.94
|
136.84
|
176.35
|
S5MANH Index
|
S&P MHC Index
|
100.00
|
160.83
|
189.83
|
270.36
|
296.44
|
351.57
|
(Dollar amounts in millions, except per share data)
|
Total Number
of Shares
Purchased (1)(2)
|
Average
Price Paid
per Share
|
Total Number of
Shares Purchased as
Part of Publicly
Announced
Programs (2)
|
Approximate
Dollar Value of
Shares that May
Yet Be Purchased
Under the
Programs
|
||||||||||||
October 1, 2019 to October 31, 2019
|
-
|
$
|
-
|
-
|
$
|
9.8
|
||||||||||
November 1, 2019 to November 30, 2019
|
273,422
|
18.64
|
267,900
|
20.0
|
||||||||||||
December 1, 2019 to December 31, 2019
|
259,981
|
19.21
|
259,981
|
15.0
|
||||||||||||
Years ended December 31,
|
2019
|
2018
|
2017
|
2016
|
2015
|
|||||||||||||||
Premiums earned, net
|
$
|
3,252.9
|
$
|
2,938.6
|
$
|
2,826.9
|
$
|
2,890.6
|
$
|
2,783.2
|
||||||||||
Administrative service fees
|
9.9
|
14.7
|
16.5
|
17.9
|
44.7
|
|||||||||||||||
Net investment income
|
62.0
|
61.9
|
51.6
|
48.9
|
45.2
|
|||||||||||||||
Other operating revenues
|
8.6
|
5.8
|
3.7
|
3.5
|
3.7
|
|||||||||||||||
Total operating revenues
|
3,333.4
|
3,021.0
|
2,898.7
|
2,960.9
|
2,876.8
|
|||||||||||||||
Net realized investments gains
|
5.8
|
0.3
|
10.8
|
17.4
|
18.9
|
|||||||||||||||
Net unrealized investment gains (losses) on equity investments
|
32.2
|
(36.5
|
)
|
-
|
-
|
-
|
||||||||||||||
Other income, net
|
4.2
|
11.3
|
6.6
|
6.5
|
7.0
|
|||||||||||||||
Total revenues
|
3,375.6
|
2,996.1
|
2,916.1
|
2,984.8
|
2,902.7
|
|||||||||||||||
Benefits and expenses:
|
||||||||||||||||||||
Claims incurred
|
2,666.3
|
2,527.6
|
2,353.1
|
2,472.2
|
2,318.7
|
|||||||||||||||
Operating expenses
|
569.4
|
554.7
|
477.2
|
493.9
|
518.7
|
|||||||||||||||
Total operating costs
|
3,235.7
|
3,082.3
|
2,830.3
|
2,966.1
|
2,837.4
|
|||||||||||||||
Interest expense
|
7.6
|
6.9
|
6.8
|
7.6
|
8.2
|
|||||||||||||||
Total benefits and expenses
|
3,243.3
|
3,089.2
|
2,837.1
|
2,973.7
|
2,845.6
|
|||||||||||||||
Income (loss) before taxes
|
132.3
|
(93.1
|
)
|
79.0
|
11.1
|
57.1
|
||||||||||||||
Income tax expense (benefit)
|
39.4
|
(29.8
|
)
|
24.5
|
(6.3
|
)
|
5.1
|
|||||||||||||
Net income (loss)
|
92.9
|
(63.3
|
)
|
54.5
|
17.4
|
52.0
|
||||||||||||||
Net loss attributable to non-controlling interest
|
-
|
-
|
-
|
-
|
(0.1
|
)
|
||||||||||||||
Net income (loss) attributable to TSM
|
$
|
92.9
|
$
|
(63.3
|
)
|
$
|
54.5
|
$
|
17.4
|
$
|
52.1
|
|||||||||
Basic net income (loss) per share (1):
|
$
|
3.98
|
$
|
(2.76
|
)
|
$
|
2.27
|
$
|
0.71
|
$
|
2.03
|
|||||||||
Diluted net income (loss) per share:
|
$
|
3.97
|
$
|
(2.76
|
)
|
$
|
2.26
|
$
|
0.71
|
$
|
2.02
|
|
|
2019
|
2018
|
2017
|
2016
|
2015
|
Years ended December 31,
|
||||||
Cash and cash equivalents
|
|
$ 109.8
|
$ 117.5
|
$ 198.9
|
$ 103.4
|
$ 197.8
|
Total assets
|
|
$ 2,818.8
|
$ 2,766.5
|
$ 3,116.8
|
$ 2,219.0
|
$ 2,206.1
|
Long-term borrowings
|
|
$ 25.7
|
$ 28.9
|
$ 32.1
|
$ 35.1
|
$ 36.8
|
Total stockholders' equity
|
|
$ 943.9
|
$ 821.9
|
$ 913.4
|
$ 863.2
|
$ 847.5
|
|
|
2019
|
2018
|
2017
|
2016
|
2015
|
Years ended December 31,
|
||||||
Medical loss ratio
|
|
84.6%
|
84.5%
|
85.6%
|
88.6%
|
86.2%
|
Operating expense ratio
|
|
14.5%
|
16.0%
|
13.6%
|
14.0%
|
15.1%
|
Medical membership (period end)
|
|
923,923
|
876,268
|
977,939
|
1,017,372
|
1,094,444
|
(1) |
Further details of the calculation of basic and diluted earnings per share are set forth in Notes 2 and 22 of the audited consolidated financial statements for the years ended December 31, 2019, 2018, and 2017.
|
(2) |
Does not reflect inter-segment eliminations.
|
I. Overview
|
56
|
Consolidated Highlights
|
57
|
Overview details
|
57
|
II. Membership
|
60
|
III. Results of Operations
|
61
|
Consolidated Operating Results
|
61
|
Managed Care Segment Operating Results
|
64
|
Life Segment Operating Results
|
67
|
Property and Casualty Segment Operating Results
|
68
|
IV. Liquidity and Capital Resources
|
70
|
V. Critical Accounting Estimates
|
76
|
VI. Recently Issued Accounting Standards
|
84
|
● |
Net income for the year was $92.9 million, an increase from a net loss of $63.3 million for the prior year. The increase in net income primarily reflects the 2018 $128.7 million unfavorable prior period reserve development recognized in the Property and Casualty segment related to Hurricane Maria and the impact of the net unrealized gains on equity investments.
|
● |
Consolidated premiums earned, net increased 10.7% year over year, to $3.3 billion, primarily reflecting an increase in membership and higher average premium rates within the Managed Care segment.
|
● |
Consolidated claims incurred for the year were $2.7 billion, up 5.5% over last year, mostly reflecting higher claims in the Managed Care segment by $254.2 million mostly driven higher enrollment, partially offset by the aforementioned $128.7 million unfavorable reserve development related to Hurricane Maria recognized by the Property and Casualty segment in 2018. The consolidated loss ratio decreased 400 basis points, to 82.0%. The Managed Care segment’s Medical Loss Ratio (“MLR”) was to 84.6%, up 10 basis points year over year.
|
● |
Consolidated operating expenses for the year were $569.4 million and the operating expense ratio was 17.5%, 130 basis points lower than last year.
|
|
Years ended December 31,
|
|||||
(Dollar amounts in millions)
|
|
2019
|
|
2018
|
|
2017
|
Premiums earned, net:
|
||||||
Managed care
|
$2,987.5
|
$2,689.1
|
$2,590.0
|
|||
Life insurance
|
182.2
|
168.6
|
161.8
|
|||
Property and casualty insurance
|
87.7
|
83.5
|
77.2
|
|||
Intersegment premiums earned
|
(4.5)
|
(2.6)
|
(2.1)
|
|||
Consolidated premiums earned, net
|
|
$3,252.9
|
|
$2,938.6
|
|
$2,826.9
|
Administrative service fees:
|
||||||
Managed care
|
$ 14.3
|
$ 19.1
|
$ 21.6
|
|||
Intersegment administrative service fees
|
(4.4)
|
(4.4)
|
(5.1)
|
|||
Consolidated administrative service fees
|
|
$ 9.9
|
|
$ 14.7
|
|
$ 16.5
|
Operating income (loss):
|
||||||
Managed care
|
$ 61.9
|
$ 26.5
|
$ 55.0
|
|||
Life insurance
|
21.9
|
19.9
|
19.4
|
|||
Property and casualty insurance
|
14.5
|
(110.1)
|
(6.0)
|
|||
Intersegment and other
|
(1.0)
|
2.0
|
-
|
|||
Consolidated operating income (loss)
|
|
$ 97.7
|
|
$ (61.3)
|
|
$ 68.4
|
|
As of December 31,
|
|||
|
2019
|
2018
|
2017
|
|
Commercial (1)
|
440,669
|
449,047
|
475,026
|
|
Medicare
|
127,789
|
108,605
|
118,451
|
|
Medicaid
|
355,465
|
318,616
|
384,462
|
|
Total
|
|
923,923
|
876,268
|
977,939
|
(1) |
Commercial membership includes corporate accounts, self-funded employers, individual accounts, Medicare Supplement, federal government employees and local government employees.
|
(Dollar amounts in millions)
|
|
2019
|
|
2018
|
|
2017
|
Years ended December 31,
|
||||||
Revenues:
|
||||||
Premiums earned, net
|
$ 3,252.9
|
$ 2,938.6
|
$ 2,826.9
|
|||
Administrative service fees
|
9.9
|
14.7
|
16.5
|
|||
Net investment income
|
62.0
|
61.9
|
51.6
|
|||
Other operating revenues
|
8.6
|
5.8
|
3.7
|
|||
Total operating revenues
|
|
3,333.4
|
|
3,021.0
|
|
2,898.7
|
Net realized investment gains
|
5.8
|
0.3
|
10.8
|
|||
Net unrealized investment gains (losses) on equity investments
|
32.2
|
(36.5)
|
-
|
|||
Other income, net
|
4.2
|
11.3
|
6.6
|
|||
Total revenues
|
|
3,375.6
|
|
2,996.1
|
|
2,916.1
|
Benefits and expenses:
|
||||||
Claims incurred
|
2,666.3
|
2,527.6
|
2,353.1
|
|||
Operating expenses
|
569.4
|
554.7
|
477.2
|
|||
Total operating costs
|
|
3,235.7
|
|
3,082.3
|
|
2,830.3
|
Interest expense
|
7.6
|
6.9
|
6.8
|
|||
Total benefits and expenses
|
|
3,243.3
|
|
3,089.2
|
|
2,837.1
|
Income (loss) before taxes
|
|
132.3
|
|
(93.1)
|
|
79.0
|
Income tax expense (benefit)
|
39.4
|
(29.8)
|
|
24.5
|
||
Net income (loss) attributable to TSM
|
|
$ 92.9
|
|
$ (63.3)
|
|
$ 54.5
|
(Dollar amounts in millions)
|
|
2019
|
|
2018
|
|
2017
|
Operating revenues:
|
||||||
Medical premiums earned, net:
|
||||||
Commercial
|
$ 801.2
|
$ 782.8
|
$ 803.3
|
|||
Medicare
|
1,408.0
|
1,130.3
|
1,035.3
|
|||
Medicaid
|
778.3
|
776.0
|
751.4
|
|||
Medical premiums earned, net
|
|
2,987.5
|
|
2,689.1
|
|
2,590.0
|
Administrative service fees
|
14.3
|
19.1
|
21.6
|
|||
Net investment income
|
23.5
|
23.8
|
16.6
|
|||
Total operating revenues
|
|
3,025.3
|
|
2,732.0
|
|
2,628.2
|
Medical operating costs:
|
||||||
Medical claims incurred
|
2,526.7
|
2,272.5
|
2,218.3
|
|||
Medical operating expenses
|
436.7
|
433.0
|
354.9
|
|||
Total medical operating costs
|
|
2,963.4
|
|
2,705.5
|
|
2,573.2
|
Medical operating income
|
|
$ 61.9
|
|
$ 26.5
|
|
$ 55.0
|
Additional data:
|
||||||
Member months enrollment:
|
||||||
Commercial:
|
||||||
Fully-insured
|
3,844,106
|
3,775,441
|
3,981,347
|
|||
Self-funded
|
1,426,353
|
1,732,219
|
1,967,668
|
|||
Total Commercial member months
|
|
5,270,459
|
|
5,507,660
|
|
5,949,015
|
Medicare member months
|
1,540,476
|
1,337,061
|
1,457,363
|
|||
Medicaid member months
|
4,257,181
|
4,555,702
|
4,631,316
|
|||
Total member months
|
|
11,068,116
|
|
11,400,423
|
|
12,037,694
|
Medical loss ratio
|
84.6%
|
84.5%
|
85.6%
|
|||
Operating expense ratio
|
|
14.5%
|
|
16.0%
|
|
13.6%
|
● |
Medical premiums generated by the Medicare business increased by $277.7 million, or 24.6%, to $1,408.0 million, primarily reflecting an increase in enrollment of approximately 203,000 member months and higher average premium rates, mainly reflecting higher membership risk score in 2019 and an increase in reimbursement rates.
|
● |
Medical premiums generated by the Commercial business increased by $18.4 million, or 2.4%, to $801.2 million. This fluctuation primarily reflects higher fully-insured member months during the year by approximately 69,000 member months and higher average premium rates, offset in part by $12.1 million related to the suspension of the HIP fee pass-through in 2019.
|
● |
Medical premiums generated by the Medicaid business increased by $2.3 million, or 0.3%, to $778.3 million. This increase primarily reflects higher premiums rates, offset by a decrease of $14.5 million related to the suspension of the HIP fee pass-through in 2019 and lower enrollment by approximately 299,000 member months. The decrease in membership follows the lower membership assigned to us by ASES when implementing the current Medicaid contract, which was effective November 1, 2018.
|
● |
The medical claims incurred of the Medicare business increased by $183.1 million, or 19.5%, during the 2019 period mostly driven by higher enrollment. The MLR at 79.8% was 340 basis points lower than the same period last year, driven by favorable prior period reserve developments in 2019 and the impact of cost containment initiatives. These decreases were partially offset by improved benefits in the 2019 product offerings.
|
● |
The medical claims incurred of the Medicaid business increased by $55.5 million, or 8.1%, during the 2019 period. The MLR at 95.4% was 690 basis points higher than the same period last year. The increased MLR reflects the higher required target MLR of the current Medicaid contract, the impact of the elimination of the HIP fee pass-through in 2019, and a timing difference in the recognition of member acuity in premiums. The current Medicaid contract requires a minimum MLR of 92%, including allocation of healthcare quality improvements expenses.
|
● |
The medical claims incurred of the Commercial business increased by $15.6 million, or 2.4%, during the 2019 period and its MLR, remained steady at 82.4% despite impact of the elimination of the HIP fee pass-through in 2019. The HIP Fee pass-through lowered the 2018 MLR by approximately 130 basis points.
|
● |
Medical premiums generated by the Medicare business increased by $95.0 million, or 9.2%, to $1,130.3 million, primarily reflecting an increase in the 2018 Medicare reimbursement rates fee-for-service benchmark for the first time since 2012, an increase in rates as the result of attaining a four-star rating in the Company’s 2018 HMO product, and higher average membership risk score. These increases were partially offset by lower enrollment by approximately 120,000 member months.
|
● |
Medical premiums generated by the Medicaid business increased by $24.6 million, or 3.3%, to $776.0 million. This increase primarily reflects higher premiums rates effective July 1, 2017 and $14.5 million related to the reinstatement of the HIP fee pass-through. These increases were offset in part by a lower enrollment by approximately 76,000 in member months and the impact of the profit sharing accrual, which lowered 2018 premiums by $4.3 million. The decrease in membership reflects the lower membership assigned by ASES when implementing the current Medicaid contract, which was effective November 1, 2018. At the effective date of the current agreement TSS was assigned by ASES approximately 280,000 subscribers. After this date, subscribers had approximately three months to select their insurance carrier, during which time TSS was able to compete for membership across Puerto Rico. As of December 31, 2018, our Medicaid membership was approximately 319,000 members.
|
● |
Medical premiums generated by the Commercial business decreased by $20.5 million, or 2.6%, to $782.8 million. This fluctuation primarily reflects lower fully-insured enrollment during the year of approximately 206,000 member months; offset in part by $12.1 million related to the reinstatement of the HIP fee pass-through in 2018 and higher average premium rates.
|
● |
The medical claims incurred of the Medicare business increased by $33.1 million, or 3.6%, during the 2018 period and its MLR decreased by 450 basis points, to 83.2%. The lower MLR reflects the higher premium rates in the 2018 period as well as cost containment initiatives implemented during the year; partially offset by the impact of the hurricane related decrease in utilization in 2017. The hurricane related decrease in utilization was estimated to lower 2017 claims by approximately $25.1 million, or 240 basis points of last year’s MLR.
|
● |
The medical claims incurred of the Commercial business increased by $22.3 million, or 3.6%, during the 2018 period and its MLR, at 82.4%, was 490 basis points higher than the same period last year primarily reflecting the decrease in utilization in the 2017 period caused by Hurricanes Irma and Maria and claim trends higher than premium trends. The hurricane related decrease in utilization was estimated to lower 2017 claims by approximately $27.8 million, or 340 basis points of last year’s MLR.
|
● |
The medical claims incurred of the Medicaid business decreased by $1.1 million, or 0.2%, during the 2018 period and its MLR decreased by 300 basis points, to 88.5%, mostly reflecting the impact of higher premium rates in 2018 and cost containment initiatives; partially offset by the impact of hurricane related decrease in utilization in 2017. The hurricane related decrease in utilization was estimated to lower 2017 claims by approximately $2.2 million, or 30 basis points of last year’s MLR.
|
(Dollar amounts in millions)
|
2019
|
2018
|
2017
|
|||||||||
Years ended December 31,
|
||||||||||||
Operating revenues:
|
||||||||||||
Premiums earned, net:
|
||||||||||||
Premiums earned
|
$
|
188.4
|
$
|
175.3
|
$
|
166.4
|
||||||
Assumed earned premiums
|
2.1
|
2.1
|
4.2
|
|||||||||
Ceded premiums earned
|
(8.3
|
)
|
(8.8
|
)
|
(8.8
|
)
|
||||||
Premiums earned, net
|
182.2
|
168.6
|
161.8
|
|||||||||
Net investment income
|
27.3
|
25.6
|
24.8
|
|||||||||
Total operating revenues
|
209.5
|
194.2
|
186.6
|
|||||||||
Operating costs:
|
||||||||||||
Policy benefits and claims incurred
|
105.9
|
99.0
|
87.3
|
|||||||||
Underwriting and other expenses
|
81.7
|
75.3
|
79.9
|
|||||||||
Total operating costs
|
187.6
|
174.3
|
167.2
|
|||||||||
Operating income
|
$
|
21.9
|
$
|
19.9
|
$
|
19.4
|
||||||
Additional data:
|
||||||||||||
Loss ratio
|
58.1
|
%
|
58.7
|
%
|
54.0
|
%
|
||||||
Expense ratio
|
44.8
|
%
|
44.7
|
%
|
49.4
|
%
|
(Dollar amounts in millions)
|
|
2019
|
|
2018
|
|
2017
|
Years ended December 31,
|
||||||
Operating revenues:
|
||||||
Premiums earned, net:
|
||||||
Premiums written
|
$ 150.5
|
$ 139.8
|
$ 143.8
|
|||
Premiums ceded
|
(52.3)
|
(60.4)
|
(62.3)
|
|||
Change in unearned premiums
|
(10.5)
|
4.1
|
(4.3)
|
|||
Premiums earned, net
|
|
87.7
|
|
83.5
|
|
77.2
|
Net investment income
|
9.8
|
10.8
|
9.5
|
|||
Total operating revenues
|
|
97.5
|
|
94.3
|
|
86.7
|
Operating costs:
|
||||||
Claims incurred
|
39.6
|
159.9
|
50.8
|
|||
Underwriting and other operating expenses
|
43.4
|
44.5
|
41.9
|
|||
Total operating costs
|
|
83.0
|
|
204.4
|
|
92.7
|
Operating income (loss)
|
|
$ 14.5
|
|
$ (110.1)
|
|
$ (6.0)
|
Additional data:
|
||||||
Loss ratio
|
45.2%
|
191.5%
|
65.8%
|
|||
Expense ratio
|
|
49.5%
|
|
53.3%
|
|
54.3%
|
(Dollar amounts in millions)
|
2019
|
2018
|
2017
|
|||||||||
Sources (uses) of cash:
|
||||||||||||
Cash (used in) provided by operating activities
|
$
|
(17.5
|
)
|
$
|
7.5
|
$
|
288.9
|
|||||
Net purchases of investment securities
|
(4.7
|
)
|
(12.6
|
)
|
(154.6
|
)
|
||||||
Net capital expenditures
|
(20.2
|
)
|
(19.8
|
)
|
(21.4
|
)
|
||||||
Capital contribution to equity method investees
|
(11.4
|
)
|
-
|
-
|
||||||||
Proceeds from long-term borrowings
|
-
|
-
|
24.3
|
|||||||||
Payments of long-term borrowings
|
(3.2
|
)
|
(3.2
|
)
|
(27.1
|
)
|
||||||
Proceeds from policyholder deposits
|
28.9
|
18.5
|
13.6
|
|||||||||
Surrenders of policyholder deposits
|
(19.9
|
)
|
(26.7
|
)
|
(22.1
|
)
|
||||||
Repurchase and retirement of common stock
|
(10.0
|
)
|
(22.4
|
)
|
(20.2
|
)
|
||||||
Net change in short-term borrowings
|
54.0
|
-
|
-
|
|||||||||
Other
|
(3.7
|
)
|
(22.7
|
)
|
14.1
|
|||||||
Net (decrease) increase in cash and cash equivalents
|
$
|
(7.7
|
)
|
$
|
(81.4
|
)
|
$
|
95.5
|
● |
In August 2019, TSS and TSV became members of the FHLBNY, which provides access to collateralized advances. The borrowing capacity of TSS and TSV is up to 30% of their admitted assets as disclosed in the most recent filing to the Commissioner of Insurance but is constrained by the amount of collateral held at the FHLBNY. See Note 3, Investment in Securities, of the Notes to Consolidated Financial Statements, included in “Item 8, Financial Statements and Supplementary Data”, of this Annual Report on Form 10-K. As of December 31, 2019, the borrowing capacity is approximately $82.2 million for TSS and $48.9 million for TSV. The outstanding balance as of December 31, 2019 for TSS and TSV is $25.0 million and $29.0 million, respectively. The average interest rate of the outstanding balance as of December 31, 2019 is 1.79%.
|
● |
As of December 31, 2019, TSS has $60.0 of available credit under repurchase agreements with broker-dealers, which are short term borrowing facilities using securities as collateral. There are no outstanding short-term borrowings under these facilities as of December 31, 2019.
|
● |
TSA has a $10.0 million revolving loan agreement with a commercial bank in Puerto Rico. This line of credit has an interest rate of 30-day LIBOR plus 25 basis points and contains certain financial and non-financial covenants that are customary for this type of facility. This line of credit matures on April 30, 2020 and has no outstanding balance as of December 31, 2019.
|
● |
The table below describes the payments due under our contractual obligations, aggregated by type of contractual obligation, including the maturity profile of our debt, operating leases and other long-term liabilities, but excludes an estimate of the future cash outflows related to the following:
|
o |
Alternative investments – The Company has $72.2 million of unfunded capital commitments related to alternative investments. These commitments were excluded from this disclosure due to the undetermined timing of their cash flows.
|
o |
Unearned premiums – This amount accounts for the premiums collected prior to the end of coverage period and does not represent a future cash outflow. As of December 31, 2019, we had $93.3 million in unearned premiums.
|
o |
Policyholder deposits – The cash outflows related to these instruments are not included because they do not have defined maturities, such that the timing of payments and withdrawals is uncertain. There are currently no significant policyholder deposits in paying status. As of December 31, 2019, our policyholder deposits had a carrying amount of $189.1 million.
|
o |
Other long-term liabilities – Due to the indeterminate nature of their cash outflows, $92.6 million of other long-term liabilities are not reflected in the following table, consisting of $34.5 million of liability for pension benefits, $10.3 million in deferred tax liabilities, and $47.8 million in liabilities to the Federal Employees’ Health Benefits Plan Program.
|
|
Contractual obligations by year
|
||||||
(Dollar amounts in millions)
|
Total
|
2020
|
2021
|
2022
|
2023
|
2024
|
Thereafter
|
Borrowings (1)
|
$ 83.3
|
$ 58.1
|
$ 4.0
|
$ 4.0
|
$ 3.9
|
$ 13.3
|
$ -
|
Operating leases
|
15.6
|
4.7
|
3.8
|
3.2
|
2.2
|
1.7
|
-
|
Purchase obligations (2)
|
592.4
|
308.7
|
68.3
|
62.1
|
55.1
|
52.1
|
46.1
|
Claim liabilities (3)
|
563.3
|
448.8
|
75.4
|
16.1
|
8.0
|
4.3
|
10.7
|
Estimated obligation for future policy benefits (4)
|
706.2
|
138.3
|
123.9
|
117.8
|
111.4
|
105.7
|
109.1
|
$ 1,960.8
|
$ 958.6
|
$ 275.4
|
$ 203.0
|
$ 180.6
|
$ 177.1
|
$ 165.9
|
(1) |
As of December 31, 2019, our long-term borrowings consist of a credit agreement with a commercial bank in Puerto Rico. Short-term borrowings represents the outstanding balance of short-term facilities available to address timing differences between cash receipts and disbursements. See the “Financing and Financing Capacity” section for additional information regarding our long-term borrowings
|
(2) |
Purchase obligations represent payments required by us under material agreements to purchase goods or services that are enforceable and legally binding and where all significant terms are specified, including: quantities to be purchased, price provisions and the timing of the transaction. Other purchase orders made in the ordinary course of business for which we are not liable are excluded from the table above. Estimated pension plan contributions amounting to $2.0 million were included within the total purchase obligations. However, this amount is an estimate which may be subject to change in view of the fact that contribution decisions are affected by various factors such as market performance, regulatory and legal requirements and plan funding policy.
|
(3) |
Claim liabilities represent the amount of our claims processed and incomplete as well as an estimate of the amount of incurred but not reported claims and loss-adjustment expenses. This amount does not include an estimate of claims to be incurred subsequent to December 31, 2019. The expected claims payments are an estimate and may differ materially from the actual claims payments made by us in the future. Also, claim liabilities are presented gross, and thus do not reflect the effects of reinsurance under which $325.0 million of reserves had been ceded at December 31, 2019.
|
(4) |
Our Life segment establishes, and carries as liabilities, actuarially determined amounts that are calculated to meet its policy obligations when a policy matures or surrenders, an insured dies or becomes disabled or upon the occurrence of other covered events. A significant portion of the estimated obligation for future policy benefits to be paid included in this table considers contracts under which we are currently not making payments and will not make payments until the occurrence of an insurable event not under our control, such as death, illness, or the surrender of a policy. We have estimated the timing of the cash flows related to these contracts based on historical experience as well as expectations of future payment patterns. The amounts presented in the table above represent the estimated cash payments for benefits under such contracts based on assumptions related to the receipt of future premiums and assumptions related to mortality, morbidity, policy lapses, renewals, retirements, disability incidence and other contingent events as appropriate for the respective product type. All estimated cash payments included in this table are not discounted to present value nor do they take into account estimated future premiums on policies in-force as of December 31, 2019 and are gross of any reinsurance recoverable. The $706.2 million total estimated cash flows for all years in the table is different from the liability of future policy benefits of $386.0 million included in our audited consolidated financial statements principally due to the time value of money. Actual cash payments to policyholders could differ significantly from the estimated cash payments as presented in this table due to differences between actual experience and the assumptions used in the estimation of these payments.
|
(Dollar amounts in millions)
|
||||
Managed care
|
$
|
340.2
|
||
Property and casualty insurance
|
322.0
|
|||
Life insurance
|
47.1
|
|||
Consolidated
|
$
|
709.3
|
Completion Factor 1
|
Claims Trend Factor 2
|
|||
(Decrease) Increase
|
(Decrease) Increase
|
|||
In unpaid claim
|
In claims trend
|
In unpaid claim
|
||
In completion factor
|
liabilities
|
factor
|
liabilities
|
|
-1.2%
|
$20.1
|
1.5%
|
$20.4
|
|
-0.8%
|
13.3
|
1.0%
|
13.6
|
|
-0.4%
|
6.6
|
0.5%
|
6.8
|
|
0.4%
|
(6.6)
|
-0.5%
|
(6.8)
|
|
0.8%
|
(13.1)
|
-1.0%
|
(13.6)
|
|
1.2%
|
(19.6)
|
-1.5%
|
(20.4)
|
(1) |
Assumes (decrease) increase in the completion factors for the most recent twelve months.
|
(2) |
Assumes (decrease) increase in the claims trend factors for the most recent twelve months.
|
(Dollar amounts in millions)
|
2018
|
2017
|
2016
|
|
|
|
|
Years ended December 31,
|
|
|
|
Total incurred claims:
|
|
|
|
As reported (1)
|
$ 2,308.5
|
$ 2,231.1
|
$ 2,356.6
|
On a retrospective basis
|
2,279.2
|
2,195.1
|
2,343.8
|
Variance
|
$ 29.3
|
$ 36.0
|
$ 12.8
|
Variance to total incurred claims as reported
|
1.3%
|
1.6%
|
0.5%
|
(1) |
Includes total claims incurred less adjustments for prior year reserve development.
|
● |
Through the management of our cash flows and investment portfolio.
|
● |
In the Commercial business we have the ability to increase the premium rates throughout the year in the monthly renewal process, when renegotiating the premiums for the following contract year of each group as they become due. We consider the actual claims trend of each group when determining the premium rates for the following contract year.
|
● |
We have available short-term borrowing facilities to address differences between cash receipts and disbursements.
|
● |
the market risk information is limited by the assumptions and parameters established in creating the related sensitivity analysis, including the impact of prepayment rates on mortgages; and
|
● |
the model assumes that the composition of assets and liabilities remains unchanged throughout the year.
|
Change in Interest Rates
|
Expected
Fair Value
|
Amount of
Decrease
|
%
Change
|
|||||
|
|
|
|
|
|
|
||
December 31, 2019:
|
|
|
|
|
|
|
||
Base Scenario
|
$
|
1,244.9
|
|
|
|
|
||
+100 bp
|
|
1,187.4
|
|
(57.5
|
)
|
(4.6
|
)%
|
|
+200 bp
|
|
1,130.8
|
|
(114.1
|
)
|
(9.2
|
)%
|
|
+300 bp
|
|
1,077.0
|
|
(167.9
|
)
|
(13.5
|
)%
|
|
December 31, 2018:
|
|
|
|
|
|
|
||
Base Scenario
|
$
|
1,202.0
|
|
|
|
|
||
+100 bp
|
|
1,148.2
|
|
(96.7
|
)
|
(7.8
|
)%
|
|
+200 bp
|
|
1,097.9
|
|
(147.0
|
)
|
(11.8
|
)%
|
|
+300 bp
|
|
1,049.4
|
|
(195.5
|
)
|
(15.7
|
)%
|
|
2019
|
|||||||||||||||||||
March 31
|
June 30
|
September 30
|
December 31
|
Total
|
||||||||||||||||
Revenues
|
||||||||||||||||||||
Premiums earned, net
|
$
|
768,002
|
$
|
859,493
|
$
|
815,021
|
$
|
810,364
|
$
|
3,252,880
|
||||||||||
Administrative service fees
|
2,632
|
2,456
|
2,607
|
2,251
|
9,946
|
|||||||||||||||
Net investment income
|
15,376
|
15,062
|
15,176
|
16,393
|
62,007
|
|||||||||||||||
Other operating revenues
|
1,577
|
1,591
|
3,167
|
2,218
|
8,553
|
|||||||||||||||
Total operating revenues
|
787,587
|
878,602
|
835,971
|
831,226
|
3,333,386
|
|||||||||||||||
Net realized investment gains
|
1,315
|
2,364
|
1,087
|
1,077
|
5,843
|
|||||||||||||||
Net realized investment gains on equity investments
|
19,669
|
3,323
|
1,267
|
7,892
|
32,151
|
|||||||||||||||
Other income, net
|
1,169
|
1,705
|
485
|
847
|
4,206
|
|||||||||||||||
Total revenues
|
809,740
|
885,994
|
838,810
|
841,042
|
3,375,586
|
|||||||||||||||
Benefits and expenses
|
||||||||||||||||||||
Claims incurred
|
623,190
|
706,304
|
680,010
|
656,752
|
2,666,256
|
|||||||||||||||
Operating expenses
|
132,663
|
134,084
|
136,882
|
165,777
|
569,406
|
|||||||||||||||
Total operating costs
|
755,853
|
840,388
|
816,892
|
822,529
|
3,235,662
|
|||||||||||||||
Interest expense
|
1,788
|
1,831
|
2,062
|
1,991
|
7,672
|
|||||||||||||||
Total benefits and expenses
|
757,641
|
842,219
|
818,954
|
824,520
|
3,243,334
|
|||||||||||||||
Income before taxes
|
52,099
|
43,775
|
19,856
|
16,522
|
132,252
|
|||||||||||||||
Income tax expense
|
17,316
|
12,849
|
5,910
|
3,300
|
39,375
|
|||||||||||||||
Net income
|
34,783
|
30,926
|
13,946
|
13,222
|
92,877
|
|||||||||||||||
Less: Net loss attributable to non-controlling interest
|
3
|
5
|
2
|
7
|
17
|
|||||||||||||||
Net income attributable to TSM
|
$
|
34,786
|
$
|
30,931
|
$
|
13,948
|
$
|
13,229
|
$
|
92,894
|
||||||||||
Basic net income per share
|
$
|
1.53
|
$
|
1.35
|
$
|
0.59
|
$
|
0.55
|
$
|
3.98
|
||||||||||
Diluted net income per share
|
$
|
1.52
|
$
|
1.35
|
$
|
0.58
|
$
|
0.55
|
$
|
3.97
|
2018
|
||||||||||||||||||||
March 31
|
June 30
|
September 30
|
December 31
|
Total
|
||||||||||||||||
Revenues
|
||||||||||||||||||||
Premiums earned, net
|
$
|
752,034
|
$
|
741,770
|
$
|
742,445
|
$
|
702,342
|
$
|
2,938,591
|
||||||||||
Administrative service fees
|
3,348
|
4,066
|
3,802
|
3,485
|
14,701
|
|||||||||||||||
Net investment income
|
13,755
|
15,707
|
16,168
|
16,279
|
61,909
|
|||||||||||||||
Other operating revenues
|
1,071
|
1,588
|
1,575
|
1,560
|
5,794
|
|||||||||||||||
Total operating revenues
|
770,208
|
763,131
|
763,990
|
723,666
|
3,020,995
|
|||||||||||||||
Net realized investment gains (losses)
|
2,942
|
(921
|
)
|
(956
|
)
|
(767
|
)
|
298
|
||||||||||||
Net unrealized investment (losses) gains on equity investments
|
(16,199
|
)
|
(776
|
)
|
5,632
|
(25,203
|
)
|
(36,546
|
)
|
|||||||||||
Other income, net
|
1,163
|
494
|
1,943
|
7,712
|
11,312
|
|||||||||||||||
Total revenues
|
758,114
|
761,928
|
770,609
|
705,408
|
2,996,059
|
|||||||||||||||
Benefits and expenses
|
||||||||||||||||||||
Claims incurred
|
618,989
|
692,138
|
648,580
|
567,906
|
2,527,613
|
|||||||||||||||
Operating expenses
|
133,134
|
134,612
|
141,026
|
145,943
|
554,715
|
|||||||||||||||
Total operating costs
|
752,123
|
826,750
|
789,606
|
713,849
|
3,082,328
|
|||||||||||||||
Interest expense
|
1,690
|
1,825
|
2,000
|
1,388
|
6,903
|
|||||||||||||||
Total benefits and expenses
|
753,813
|
828,575
|
791,606
|
715,237
|
3,089,231
|
|||||||||||||||
Income (loss) before taxes
|
4,301
|
(66,647
|
)
|
(20,997
|
)
|
(9,829
|
)
|
(93,172
|
)
|
|||||||||||
Income tax expense (benefit)
|
387
|
(27,901
|
)
|
(3,430
|
)
|
1,078
|
(29,866
|
)
|
||||||||||||
Net income (loss)
|
3,914
|
(38,746
|
)
|
(17,567
|
)
|
(10,907
|
)
|
(63,306
|
)
|
|||||||||||
Less: Net income (loss) attributable to non-controlling interest
|
-
|
1
|
-
|
(5
|
)
|
(4
|
)
|
|||||||||||||
Net income (loss) attributable to TSM
|
$
|
3,914
|
$
|
(38,747
|
)
|
$
|
(17,567
|
)
|
$
|
(10,902
|
)
|
$
|
(63,302
|
)
|
||||||
Basic net income (loss) per share
|
$
|
0.17
|
$
|
(1.68
|
)
|
$
|
(0.77
|
)
|
$
|
(0.48
|
)
|
$
|
(2.76
|
)
|
||||||
Diluted net income (loss) per share
|
$
|
0.17
|
$
|
(1.68
|
)
|
$
|
(0.77
|
)
|
$
|
(0.48
|
)
|
$
|
(2.76
|
)
|
Item 9. |
Changes in and Disagreements with Accountants on Accounting and Financial Disclosures
|
Item 9A. |
Controls and Procedures
|
● |
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
|
● |
provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with GAAP and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and
|
● |
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the consolidated financial statements.
|
Financial Statements
|
Description
|
|
|
F-1
|
Report of Independent Registered Public Accounting Firm
|
|
|
F-2
|
Consolidated Balance Sheets as of December 31, 2019 and 2018
|
|
|
F-3
|
Consolidated Statements of Earnings for the years ended December 31, 2019, 2018 and 2017
|
|
|
F-4
|
Consolidated Statements of Comprehensive Income for the years ended December 31, 2019, 2018 and 2017
|
|
|
F-5
|
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2019, 2018 and 2017
|
|
|
F-6
|
Consolidated Statements of Cash Flows for the years ended December 31, 2019, 2018 and 2017
|
|
|
F-7
|
Notes to Consolidated Financial Statements – December 31, 2019, 2018 and 2017
|
Financial Statements Schedules
|
Description
|
|
|
S-1
|
Schedule II – Condensed Financial Information of the Registrant
|
|
|
S-2
|
Schedule III – Supplementary Insurance Information
|
|
|
S-3
|
Schedule IV – Reinsurance
|
|
|
S-4
|
Schedule V – Valuation and Qualifying Accounts
|
|
|
S-5
|
Schedule VI – Supplementary Information Concerning Consolidated Property and Casualty Insurance Operations
|
Exhibits
|
Description
|
|
|
Amended and Restated Articles of Incorporation (incorporated herein by reference to Exhibit 3(i)(d) to TSM’s Annual Report on Form 10-K for the Year Ended December 31, 2007 (File No. 001-33865).
|
|
|
|
Amendment to Article Tenth of the Amended and Restated Articles of Incorporation of Triple-S Management Corporation, incorporated by reference to Exhibit 3(i)(b) to TSM’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 (File No. 001-33865).
|
|
|
|
Articles of Incorporation of Triple-S Management Corporation, as currently in effect, incorporated by reference to Exhibit 3(i)(c) to TSM’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 (File No. 001-33865).
|
|
|
|
Amendments to Article Tenth and Thirteenth of the Amended and Restated Articles of Incorporation of Triple-S Management Corporation (incorporated herein by reference to Exhibit 3(i)(d) to TSM’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017 (File No. 001-33865)).
|
|
|
|
Composite Amended and Restated Articles of Incorporation of Triple-S Management Corporation (incorporated herein by reference to Exhibit 3(i)(e) to TSM’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017 (File No. 001-33865)).
|
|
|
|
Amended and Restated Bylaws of Triple-S Management Corporation (incorporated herein by reference to Exhibit 3.1 to TSM’s Current Report on Form 8-K filed on June 11, 2010 (File No. 001-33865)).
|
|
|
|
Amendment to the Contract between Administración de Seguros de Salud de Puerto Rico (ASES) and Triple-S Salud, Inc. to administer the provision of physical & behavioral health services under the Government Health Plan Program (incorporated herein by reference to Exhibit 10.1 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2017 (File No. 001-33865).
|
|
|
|
Amendment to Extend Contract for the Provision of Physical & Behavioral Health Services under the Government Health Plan Program dated as of June 30, 2018, by and between the Administracion de Seguros de Salud de Puerto Rico and Triple-S Salud, Inc. (incorporated herein by reference to Exhibit 10.1 to TSM’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018 (File No. 001-33865)).
|
|
Amendment to the Contract between Administración de Seguros de Salud de Puerto Rico (ASES) and Triple-S Salud, Inc. to administer the provision of physical and behavioral health services under the Government Health Plan (incorporated herein by reference to Exhibit 10.3 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2019 (File No. 001-33865)).
|
|
|
|
Federal Employees Health Benefits Contract (incorporated herein by reference to Exhibit 10.5 to TSM's General Form of Registration of Securities on Form 10 (File No. 001-33865)).
|
|
|
|
Credit Agreement with FirstBank Puerto Rico in the amount of $41,000,000 (incorporated herein by reference to Exhibit 10.6 to TSM's General Form of Registration of Securities on Form 10 (File No. 001-33865)).
|
Exhibits
|
Description
|
|
|
Credit Agreement with FirstBank Puerto Rico in the amount of $20,000,000 (incorporated herein by reference to Exhibit 10.7 to TSM's General Form of Registration of Securities on Form 10 (File No. 001-33865)).
|
|
|
|
Non-Contributory Retirement Program (incorporated herein by reference to Exhibit 10.8 to TSM's General Form of Registration of Securities on Form 10 (File No. 001-33865)).
|
|
|
|
Blue Shield License Agreement by and between BCBSA and TSM, including revisions, if any, adopted by Member Plans through the November 19, 2009 meeting (incorporated herein by reference to Exhibit 10.11 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2009 (File No. 001-33865)).
|
|
|
|
Blue Shield Controlled Affiliate License Agreement by and among BCBSA, TSS and TSM, including revisions, if any, adopted by Member Plans through the November 19, 2009 meeting (incorporated herein by reference to Exhibit 10.12 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2009 (File No. 001-33865)).
|
|
|
|
Blue Cross License Agreements by and between BCBSA and TSM, including revisions, if any, adopted by Member Plans through the November 19, 2009 meeting (incorporated herein by reference to Exhibit 10.13 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2009 (File No. 001-33865)).
|
|
|
|
Blue Cross Controlled Affiliate License Agreement by and among BCBSA, TSS and TSM, including revisions, if any, adopted by Member Plans through the November 19, 2009 meeting (incorporated herein by reference to Exhibit 10.14 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2009 (File No. 001-33865)).
|
|
|
|
6.30% Senior Unsecured Notes Due September 2019 Note Purchase Agreement, dated September 30, 2004, between Triple-S Management Corporation, Triple-S, Inc. and various institutional accredited investors (incorporated herein by reference to Exhibit 10.15 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2005 (File No. 001-33865)).
|
|
|
|
6.60% Senior Unsecured Notes Due December 2020 Note Purchase Agreement, dated December 15, 2005, between Triple-S Management Corporation and various institutional accredited investors (incorporated herein by reference to Exhibit 10.16 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2005 (File No. 001-33865)).
|
|
|
|
6.70% Senior Unsecured Notes Due December 2021 Note Purchase Agreement, dated January 23, 2006, between Triple-S Management Corporation and various institutional accredited investors (incorporated herein by reference to Exhibit 10.1 to TSM’s Quarterly Report on Form 10-Q for the Quarter Ended March 31, 2006 (File No. 001-33865)).
|
|
|
|
TSM 2007 Incentive Plan, dated October 16, 2007 (incorporated herein by reference to Exhibit C to TSM’s 2007 Proxy Statement (File No. 001-33865)).
|
|
|
|
Software License and Maintenance Agreement between Quality Care Solutions, Inc, and TSS dated August 16, 2007 (incorporated herein by reference to Exhibit 10.15 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-33865)).
|
Exhibits
|
Description
|
|
|
Addendum Number One to the Software License and Maintenance Agreement between Quality Care Solutions, Inc, and TSS (incorporated herein by reference to Exhibit 10.15(a) to TSM’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-33865)).
|
|
|
|
Addendum Number Two to the Software License and Maintenance Agreement between Quality Care Solutions, Inc, and TSS (incorporated herein by reference to Exhibit 10.15(b) to TSM’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-33865)).
|
|
|
|
Addendum Number Three to the Software License and Maintenance Agreement between Quality Care Solutions, Inc, and TSS (incorporated herein by reference to Exhibit 10.15(c) to TSM’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-33865)).
|
|
|
|
Work Order Agreement between Quality Care Solutions, Inc. and TSS (incorporated herein by reference to Exhibit 10.16 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-33865)).
|
|
|
|
Agreement between the Administracion de Seguros de Salud de Puerto Rico and Triple-S Salud, Inc. for the Provision of Physical & Behavioral Health Services under the Government Health Plan Program dated as of September 21, 2018, (incorporated herein by reference to Exhibit 10.1 to TSM’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 (File No. 001-33865)).
|
|
|
|
Agreement between the Puerto Rico Health Insurance Administration and TSS for the provision of the physical & behavioral health services under the Government Health Plan Program (incorporated herein by reference to Exhibit 10.1 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2014 (File No. 001-33865)).
|
|
|
|
Settlement and Release Agreement between Triple-S Management Corporation, Triple-S Salud, Inc., and the Health Insurance Administration of Puerto Rico (incorporated herein by reference to Exhibit 10.22 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2015 (File No. 001-33865)).
|
|
|
|
Resolution Agreement between Triple-S Management Corporation, Triple-S Salud, Inc., and the Department of Health and Human Services (incorporated herein by reference to Exhibit 10.23 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2015 (File No. 001-33865)).
|
|
|
|
Employment Contract between Roberto García-Rodríguez and TSM (incorporated herein by reference to Exhibit 10.1 to TSM’s Current Report on Form 8-K filed on December 26, 2018 (File No. 001-33865)).
|
|
|
|
Credit Agreement dated December 28, 2016 by and between Triple-S Management Corporation and FirstBank Puerto Rico (incorporated herein by reference to Exhibit 10.1 to TSM’s Current Report on Form 8-K filed on December 30, 2016 (File No. 001-33865)).
|
|
|
|
TSM 2017 Incentive Plan (incorporated herein by reference to Exhibit 99.1 to TSM’s Form S-8 dated May 11, 2017 (File No. 001-33865)).
|
|
|
|
Amendment to Extend Contract for the Provision of Physical & Behavioral Health Services under the Government Health Plan Program (incorporated herein by reference to Exhibit 10.1 to TSM’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2017 (File No. 001-33865)).
|
Exhibits
|
Description
|
|
|
Master Services Agreement, dated as of August 29, 2017, by and between Triple-S Salud, Inc. and OptumInsight, Inc. (incorporated herein by reference to Exhibit 10.2 to TSM’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 (File No. 001-33865)).
|
|
|
|
Amendment to Extend Contract for the Provision of Physical & Behavioral Health Services under the Government Health Plan Program dated as of September 28, 2017, by and between the Administracion de Seguros de Salud de Puerto Rico and Triple-S Salud, Inc. (incorporated herein by reference to Exhibit 10.1 to TSM’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 (File No. 001-33865)).
|
|
|
|
Statement re computation of per share earnings; an exhibit describing the computation of the earnings per share has been omitted as the detail necessary to determine the computation of earnings per share can be clearly determined from the material contained in Part II of this Annual Report on Form 10-K.
|
|
|
|
Code of Ethics for Financial Managers and Supervisors.
|
|
|
|
List of Subsidiaries of TSM
|
|
|
|
Consent of Independent Registered Public Accounting Firm (Deloitte & Touche LLP).
|
|
|
|
Certification of the President and Chief Executive Officer required by Rule 13a-14(a)/15d-14(a).
|
|
|
|
Certification of the Vice President of Finance and Chief Financial Officer required by Rule 13a-14(a)/15d-14(a).
|
|
|
|
Certification of the President and Chief Executive Officer required pursuant to 18 U.S. Section 1350.
|
|
|
|
Certification of the Vice President of Finance and Chief Financial Officer required pursuant to 18 U.S. Section 1350.
|
|
|
|
Incentive Compensation Recoupment Policy (incorporated herein by reference to Exhibit 99.1 to TSM’s Annual Report on Form 10-K for the year ended December 31, 2010 (File No. 001-33865)).
|
By:
|
/s/ Roberto García-Rodríguez
|
|
Date:
|
February 28, 2020
|
|
|
Roberto García-Rodríguez
|
|
|
||
|
President and Chief Executive Officer
|
|
|
By:
|
/s/ Juan J. Román-Jiménez
|
|
Date:
|
February 28, 2020
|
|
|
Juan J. Román-Jiménez
|
|
|
||
|
Executive Vice President and Chief Financial Officer
|
|
|
By:
|
/s/ Luis A. Clavell-Rodríguez
|
|
Date:
|
February 28, 2020
|
|
|
Luis A. Clavell-Rodríguez
|
|
|
||
|
Director and Chairman of the Board
|
|
|
By:
|
/s/ Cari M. Domínguez
|
|
Date:
|
February 28, 2020
|
|
|
Cari M. Domínguez
|
|
|
||
|
Director and Vice-Chairman of the Board
|
|
|
By:
|
/s/ David H. Chafey, Jr.
|
|
Date:
|
February 28, 2020
|
|
|
David H. Chafey, Jr.
|
|
|
||
|
Director
|
|
|
By:
|
/s/ Jorge L. Fuentes-Benejam
|
|
Date:
|
February 28, 2020
|
|
|
Jorge L. Fuentes-Benejam
|
|
|
||
|
Director
|
|
|
By:
|
/s/ Manuel Figueroa-Collazo
|
|
Date:
|
February 28, 2020
|
|
|
Manuel Figueroa-Collazo
|
|
|
||
|
Director
|
|
|
By:
|
/s/ Joseph A. Frick
|
|
Date:
|
February 28, 2020
|
|
|
Joseph A. Frick
|
|
|
||
|
Director
|
|
|
By:
|
/s/ Roberto Santa María-Ros
|
|
Date:
|
February 28, 2020
|
|
|
Roberto Santa María-Ros
|
|
|
||
|
Director
|
|
|
By:
|
/s/ Gail B. Marcus
|
|
Date:
|
February 28, 2020
|
|
|
Gail B. Marcus
|
|
|
||
|
Director
|
|
|
Report of Independent Registered Public Accounting Firm
|
2
|
Consolidated Financial Statements
|
|
Consolidated Balance Sheets
|
5
|
Consolidated Statements of Earnings
|
6
|
Consolidated Statements of Comprehensive Income
|
7
|
Consolidated Statements of Stockholders’ Equity
|
8
|
Consolidated Statements of Cash Flows
|
9
|
Notes to Consolidated Financial Statements
|
11–74
|
• |
We tested the effectiveness of controls over management’s goodwill impairment evaluation, including those over the forecasts and the selection of the discount rates.
|
• |
We evaluated management’s ability to accurately forecast by comparing actual results to management’s historical forecasts.
|
• |
We evaluated the reasonableness of management’s forecasts by comparing forecasts to (1) historical results, (2) internal communications to management and the Board of Directors, and (3) forecasted information included in press releases, analyst and industry reports of the Company and companies in its peer group.
|
• |
We considered the impact of changes in the regulatory environment on management’s forecasts.
|
• |
With the assistance of our fair value specialists, we evaluated the reasonableness of the (1) valuation methodology, including testing the mathematical accuracy of the calculation and (2) discount rate and company specific risks by:
|
o |
Testing the source information underlying the determination of the discount rate and the mathematical accuracy of the calculation
|
o |
Developing a range of independent discount rate estimates and comparing to those selected by management.
|
• |
We tested the effectiveness of controls related to managed care claim liabilities, including those over the assumptions used to estimate the medical costs incurred but not yet paid.
|
• |
We evaluated the methods and assumptions used by management to estimate the medical costs incurred but not yet paid by:
|
o |
Testing the underlying data that served as the basis for the actuarial analysis, including historical paid claims, to test that the inputs to the actuarial estimate were reasonable.
|
o |
Comparing management prior-year assumptions of payment experience, trend factors and completion factors to actuals incurred during the current year.
|
• |
With the assistance of our actuarial specialists, we developed an independent estimate of medical costs incurred but not yet paid and compared our estimate to management’s estimate
|
• |
We tested the effectiveness of controls related to property and casualty claims liabilities, including those over the assumptions about the frequency and severity of claim in projecting the settlement value of reported and unreported claims.
|
• |
We tested the underlying data that served as the basis for the estimate, including historical claims, to test that the inputs to the actuarial estimate were reasonable.
|
• |
With the assistance of our actuarial specialists, we tested the mathematical accuracy of the calculation and evaluated the methods and assumptions used by management to estimate the liabilities.
|
Assets
|
2019
|
2018
|
||||||
Investments and cash
|
||||||||
Fixed maturities available for sale, at fair value (amortized cost of $1,173,043 in 2019 and $1,168,369 in 2018)
|
$
|
1,242,883
|
$
|
1,199,402
|
||||
Fixed maturities held to maturity, at amortized cost (fair value of $2,019 in 2019 and $2,619 in 2018)
|
1,860
|
2,492
|
||||||
Equity investments, at fair value (cost of $242,069 in 2019 and $265,858 in 2018)
|
287,525
|
279,164
|
||||||
Other invested assets, at net asset value (amortized cost of $97,575 in 2019 and $72,627 in 2018)
|
100,508
|
74,015
|
||||||
Policy loans
|
10,861
|
9,469
|
||||||
Cash and cash equivalents
|
109,837
|
117,544
|
||||||
Total investments and cash
|
1,753,474
|
1,682,086
|
||||||
Premium and other receivables, net
|
567,692
|
628,444
|
||||||
Deferred policy acquisition costs and value of business acquired
|
234,885
|
215,159
|
||||||
Property and equipment, net
|
88,588
|
81,923
|
||||||
Deferred tax asset
|
77,294
|
79,010
|
||||||
Goodwill
|
28,599
|
25,397
|
||||||
Other assets
|
68,294
|
48,229
|
||||||
Total assets
|
$
|
2,818,826
|
$
|
2,760,248
|
||||
Liabilities and Stockholders’ Equity
|
||||||||
Claim liabilities
|
$
|
709,258
|
936,789
|
|||||
Liability for future policy benefits
|
386,017
|
361,495
|
||||||
Unearned premiums
|
93,301
|
82,990
|
||||||
Policyholder deposits
|
189,120
|
174,110
|
||||||
Liability to Federal Employees’ Health Benefits and Federal Employees' Programs
|
47,781
|
44,926
|
||||||
Accounts payable and accrued liabilities
|
325,761
|
275,228
|
||||||
Deferred tax liability
|
10,257
|
3,245
|
||||||
Short-term borrowings
|
54,000
|
-
|
||||||
Long-term borrowings
|
25,694
|
28,883
|
||||||
Liability for pension benefits
|
34,465
|
31,274
|
||||||
Total liabilities
|
1,875,654
|
1,938,940
|
||||||
|
||||||||
Commitments and contingencies
|
|
|
||||||
|
||||||||
Stockholders’ equity
|
||||||||
Triple-S Management Corporation stockholders' equity Common stock Class A, $1 par value. Authorized 100,000,000 shares; issued and outstanding 950,968 at December 31, 2018
|
-
|
951
|
||||||
Common stock Class B, $1 par value. Authorized 100,000,000 shares; issued and outstanding 23,799,633 and 21,980,492 shares at December 31, 2019 and 2018, respectively
|
23,800
|
21,980
|
||||||
Additional paid-in capital
|
60,504
|
34,021
|
||||||
Retained earnings
|
830,198
|
761,970
|
||||||
Accumulated other comprehensive income, net
|
29,363
|
3,062
|
||||||
Total Triple-S Management Corporation stockholders' equity
|
943,865
|
821,984
|
||||||
Non-controlling interest in consolidated subsidiary
|
(693
|
)
|
(676
|
)
|
||||
Total stockholders' equity
|
943,172
|
821,308
|
||||||
Total liabilities and stockholders’ equity
|
$
|
2,818,826
|
$
|
2,760,248
|
|
2019
|
2018
|
2017
|
|||||||||
Revenues:
|
||||||||||||
Premiums, net
|
$
|
3,252,880
|
$
|
2,938,591
|
$
|
2,826,932
|
||||||
Administrative service fees
|
9,946
|
14,701
|
16,514
|
|||||||||
Net investment income
|
62,007
|
61,909
|
51,615
|
|||||||||
Other operating revenues
|
8,553
|
5,794
|
3,660
|
|||||||||
Total operating revenues
|
3,333,386
|
3,020,995
|
2,898,721
|
|||||||||
Net realized investment gains (losses):
|
||||||||||||
Total other-than-temporary impairment losses on securities
|
-
|
-
|
(49
|
)
|
||||||||
Net realized gains, excluding other-than-temporary impairment losses on securities
|
5,843
|
298
|
10,880
|
|||||||||
Total net realized investment gains
|
5,843
|
298
|
10,831
|
|||||||||
|
||||||||||||
Net unrealized investment gains (losses) on equity investments
|
32,151
|
(36,546
|
)
|
-
|
||||||||
Other income, net
|
4,206
|
11,312
|
6,533
|
|||||||||
Total revenues
|
3,375,586
|
2,996,059
|
2,916,085
|
|||||||||
Benefits and expenses:
|
||||||||||||
Claims incurred, net of reinsurance
|
2,666,256
|
2,527,613
|
2,353,101
|
|||||||||
Operating expenses
|
569,406
|
554,715
|
477,213
|
|||||||||
Total operating costs
|
3,235,662
|
3,082,328
|
2,830,314
|
|||||||||
Interest expense
|
7,672
|
6,903
|
6,794
|
|||||||||
Total benefits and expenses
|
3,243,334
|
3,089,231
|
2,837,108
|
|||||||||
Income (loss) before taxes
|
132,252
|
(93,172
|
)
|
78,977
|
||||||||
Income tax expense (benefit)
|
39,375
|
(29,866
|
)
|
24,496
|
||||||||
Net income (loss)
|
92,877
|
(63,306
|
)
|
54,481
|
||||||||
Less: Net loss attributable to non-controlling interest
|
17
|
4
|
5
|
|||||||||
|
||||||||||||
Net income (loss) attributable to Triple-S Management Corporation
|
$
|
92,894
|
$
|
(63,302
|
)
|
$
|
54,486
|
|||||
|
||||||||||||
Earnings per share attributable to Triple-S Management Corporation
|
||||||||||||
Basic net income (loss) per share
|
$
|
3.98
|
$
|
(2.76
|
)
|
$
|
2.27
|
|||||
Diluted net income (loss) per share
|
$
|
3.97
|
$
|
(2.76
|
)
|
$
|
2.26
|
|
2019
|
2018
|
2017
|
|||||||||
Net income (loss)
|
$
|
92,877
|
$
|
(63,306
|
)
|
$
|
54,481
|
|||||
Other comprehensive income (loss), net of tax:
|
||||||||||||
Net unrealized change in fair value of available for sale securities, net of taxes
|
30,522
|
(9,048
|
)
|
13,867
|
||||||||
Defined benefit pension plan:
|
||||||||||||
Actuarial (loss) gain, net
|
(4,221
|
)
|
738
|
(5,028
|
)
|
|||||||
Prior service credit, net
|
-
|
-
|
20
|
|||||||||
Total other comprehensive income (loss), net of tax
|
26,301
|
(8,310
|
)
|
8,859
|
||||||||
Comprehensive income (loss)
|
119,178
|
(71,616
|
)
|
63,340
|
||||||||
Comprehensive loss attributable to non-controlling interest
|
17
|
4
|
5
|
|||||||||
Comprehensive income (loss) attributable to Triple-S Management Corporation
|
$
|
119,195
|
$
|
(71,612
|
)
|
$
|
63,345
|
|
Class A
Common
Stock
|
Class B
Common
Stock
|
Additional
Paid-in
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Triple-S
Management
Corporation
Stockholders’
Equity
|
Non-controlling
Interest in
Consolidated
Subsidiary
|
Total
Stockholders’
Equity
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
Balance, December 31, 2016
|
$
|
951
|
$
|
23,321
|
$
|
65,592
|
$
|
730,904
|
$
|
42,395
|
$
|
863,163
|
$
|
(677
|
)
|
$
|
862,486
|
|||||||||||||||
Share-based compensation
|
-
|
167
|
6,909
|
-
|
-
|
7,076
|
-
|
7,076
|
||||||||||||||||||||||||
Repurchase and retirement of common stock
|
-
|
(861
|
)
|
(19,359
|
)
|
-
|
-
|
(20,220
|
)
|
-
|
(20,220
|
)
|
||||||||||||||||||||
Comprehensive income (loss)
|
-
|
-
|
-
|
54,486
|
8,859
|
63,345
|
(5
|
)
|
63,340
|
|||||||||||||||||||||||
Balance, December 31, 2017
|
$
|
951
|
$
|
22,627
|
$
|
53,142
|
$
|
785,390
|
$
|
51,254
|
$
|
913,364
|
$
|
(682
|
)
|
$
|
912,682
|
|||||||||||||||
Share-based compensation
|
-
|
287
|
3,070
|
-
|
-
|
3,357
|
-
|
3,357
|
||||||||||||||||||||||||
Repurchase and retirement of common stock
|
-
|
(934
|
)
|
(22,191
|
)
|
-
|
-
|
(23,125
|
)
|
-
|
(23,125
|
)
|
||||||||||||||||||||
Comprehensive income (loss)
|
-
|
-
|
-
|
(63,302
|
)
|
(8,310
|
)
|
(71,612
|
)
|
6
|
(71,606
|
)
|
||||||||||||||||||||
Cumulative effect adjustment due to implementation of ASU 2016-01
|
-
|
-
|
-
|
39,882
|
(39,882
|
)
|
-
|
-
|
-
|
|||||||||||||||||||||||
Balance, December 31, 2018
|
$
|
951
|
$
|
21,980
|
$
|
34,021
|
$
|
761,970
|
$
|
3,062
|
$
|
821,984
|
$
|
(676
|
)
|
$
|
821,308
|
|||||||||||||||
Share-based compensation
|
-
|
222
|
11,383
|
-
|
-
|
11,605
|
-
|
11,605
|
||||||||||||||||||||||||
Repurchase and retirement of common stock
|
-
|
(534
|
)
|
(9,573
|
)
|
-
|
-
|
(10,107
|
)
|
-
|
(10,107
|
)
|
||||||||||||||||||||
Issuance of Common Stock
|
48
|
-
|
1,151
|
-
|
-
|
1,199
|
-
|
1,199
|
||||||||||||||||||||||||
Stock dividend
|
-
|
1,133
|
23,522
|
(24,655
|
)
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||
Dividend
|
-
|
-
|
-
|
(11
|
)
|
-
|
(11
|
)
|
-
|
(11
|
)
|
|||||||||||||||||||||
Common Stock Class A conversion to Class B
|
(999
|
)
|
999
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||
Comprehensive income (loss)
|
-
|
-
|
-
|
92,894
|
26,301
|
119,195
|
(17
|
)
|
119,178
|
|||||||||||||||||||||||
Balance, December 31, 2019
|
$
|
-
|
$
|
23,800
|
$
|
60,504
|
$
|
830,198
|
$
|
29,363
|
$
|
943,865
|
$
|
(693
|
)
|
$
|
943,172
|
|
2019
|
2018
|
2017
|
|||||||||
Cash flows from operating activities
|
||||||||||||
Net income (loss)
|
$
|
92,877
|
$
|
(63,306
|
)
|
$
|
54,481
|
|||||
Adjustments to reconcile net income to net cash provided by operating activities
|
||||||||||||
Depreciation and amortization
|
14,600
|
13,535
|
13,198
|
|||||||||
Net amortization of investments
|
2,326
|
3,976
|
10,114
|
|||||||||
Additions to the allowance for doubtful receivables
|
18,899
|
11,321
|
1,462
|
|||||||||
Deferred tax benefit
|
3,661
|
(32,078
|
)
|
(9,916
|
)
|
|||||||
Net realized investment gains on sale of securities
|
(5,843
|
)
|
(298
|
)
|
(10,831
|
)
|
||||||
Net unrealized (gains) losses on equity investments
|
(32,151
|
)
|
36,546
|
-
|
||||||||
Interest credited to policyholder deposits
|
5,978
|
5,722
|
5,677
|
|||||||||
Share-based compensation
|
11,605
|
3,357
|
7,076
|
|||||||||
(Increase) decrease in assets
|
||||||||||||
Premium and other receivables, net
|
41,853
|
259,561
|
(614,424
|
)
|
||||||||
Deferred policy acquisition costs and value of business acquired
|
(21,746
|
)
|
(12,258
|
)
|
(6,596
|
)
|
||||||
Deferred taxes
|
(226
|
)
|
946
|
4,946
|
||||||||
Other assets
|
1,385
|
(1,470
|
)
|
5,117
|
||||||||
Increase (decrease) in liabilities
|
||||||||||||
Claim liabilities
|
(227,531
|
)
|
(170,087
|
)
|
618,933
|
|||||||
Liability for future policy benefits
|
24,522
|
21,988
|
18,275
|
|||||||||
Unearned premiums
|
10,311
|
(3,359
|
)
|
7,039
|
||||||||
Liability to FEHBP
|
2,855
|
(7,361
|
)
|
17,917
|
||||||||
Accounts payable and accrued liabilities
|
39,799
|
(59,276
|
)
|
166,450
|
||||||||
Net cash (used in) provided by operating activities
|
(16,826
|
)
|
7,459
|
288,918
|
|
2019
|
2018
|
2017
|
|||||||||
Cash flows from investing activities
|
||||||||||||
Proceeds from investments sold or matured
|
||||||||||||
Securities available for sale:
|
||||||||||||
Fixed maturities sold
|
$
|
424,239
|
$
|
1,302,810
|
$
|
463,232
|
||||||
Fixed maturities matured
|
21,258
|
24,945
|
18,893
|
|||||||||
Securities held to maturity:
|
||||||||||||
Fixed maturities matured
|
1,708
|
8,182
|
2,712
|
|||||||||
Equity investments sold
|
169,153
|
203,841
|
59,963
|
|||||||||
Other invested assets sold
|
4,554
|
3,714
|
-
|
|||||||||
Acquisition of investments
|
||||||||||||
Securities available for sale
|
||||||||||||
Fixed maturities
|
(449,043
|
)
|
(1,343,346
|
)
|
(560,304
|
)
|
||||||
Securities held to maturity
|
||||||||||||
Fixed maturities
|
(1,078
|
)
|
(8,356
|
)
|
(2,197
|
)
|
||||||
Equity investments
|
(143,972
|
)
|
(156,486
|
)
|
(134,834
|
)
|
||||||
Other invested assets
|
(28,501
|
)
|
(47,221
|
)
|
-
|
|||||||
Other investments
|
(2,981
|
)
|
(705
|
)
|
(2,064
|
)
|
||||||
Net disbursements for policy loans
|
(1,392
|
)
|
(392
|
)
|
(513
|
)
|
||||||
Net capital expenditures
|
(20,820
|
)
|
(19,840
|
)
|
(21,359
|
)
|
||||||
Capital contribution to equity method investees
|
(11,418
|
)
|
-
|
-
|
||||||||
Net cash used in investing activities
|
(38,293
|
)
|
(32,854
|
)
|
(176,471
|
)
|
||||||
Cash flows from financing activities
|
||||||||||||
Change in outstanding checks in excess of bank balances
|
(2,384
|
)
|
(22,243
|
)
|
12,683
|
|||||||
Proceeds from short-term borrowings
|
54,000
|
-
|
-
|
|||||||||
Repayments of long-term borrowings
|
(3,236
|
)
|
(3,236
|
)
|
(2,836
|
)
|
||||||
Repurchase and retirement of common stock
|
(9,989
|
)
|
(22,377
|
)
|
(20,220
|
)
|
||||||
Net proceeds from revolving line of credit
|
-
|
-
|
1,964
|
|||||||||
Dividends paid
|
(11
|
)
|
-
|
-
|
||||||||
Proceeds from policyholder deposits
|
28,879
|
18,531
|
13,557
|
|||||||||
Surrenders of policyholder deposits
|
(19,847
|
)
|
(26,677
|
)
|
(22,082
|
)
|
||||||
Net cash provided by (used in) financing activities
|
47,412
|
(56,002
|
)
|
(16,934
|
)
|
|||||||
Net (decrease) increase in cash and cash equivalents
|
(7,707
|
)
|
(81,397
|
)
|
95,513
|
|||||||
Cash and cash equivalents
|
||||||||||||
Beginning of year
|
117,544
|
198,941
|
103,428
|
|||||||||
End of year
|
$
|
109,837
|
$
|
117,544
|
$
|
198,941
|
1. |
Nature of Business
|
2. |
Significant Accounting Policies
|
a. |
Managed Care
|
c. |
Property and Casualty Insurance
|
Asset Category
|
Estimated
Useful Life
|
|
|
Buildings
|
35 years
|
Building improvements
|
5 years
|
Leasehold improvements
|
Lesser of lease term or 10 years
|
Office furniture
|
7 years
|
Computer software
|
3 to 10 years
|
Computer equipment, equipment, and automobiles
|
3 to 5 years
|
3. |
Investment in Securities
|
|
2019
|
|||||||||||||||
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Estimated
Fair
Value
|
||||||||||||
|
||||||||||||||||
Fixed maturities available for sale
|
||||||||||||||||
Obligations of government- sponsored enterprises
|
$
|
17,209
|
$
|
477
|
$
|
-
|
$
|
17,686
|
||||||||
U.S. Treasury securities and obligations of U.S. government instrumentalities
|
102,230
|
4,779
|
-
|
107,009
|
||||||||||||
Municipal securities
|
595,051
|
34,735
|
(22
|
)
|
629,764
|
|||||||||||
Corporate bonds
|
187,096
|
21,721
|
(74
|
)
|
208,743
|
|||||||||||
Residential mortgage-backed securities
|
262,783
|
8,073
|
(320
|
)
|
270,536
|
|||||||||||
Collateralized mortgage obligations
|
8,674
|
471
|
-
|
9,145
|
||||||||||||
Total fixed maturities available for sale
|
$
|
1,173,043
|
$
|
70,256
|
$
|
(416
|
)
|
$
|
1,242,883
|
|
2018
|
|||||||||||||||
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Estimated
Fair
Value
|
||||||||||||
|
||||||||||||||||
Fixed maturities available for sale
|
||||||||||||||||
Obligations of government- sponsored enterprises
|
$
|
21,470
|
$
|
120
|
$
|
(1
|
)
|
$
|
21,589
|
|||||||
U.S. Treasury securities and obligations of U.S. government instrumentalities
|
174,675
|
2,349
|
-
|
177,024
|
||||||||||||
Obligations of the Commonwealth of Puerto Rico and its instrumentalities
|
8,295
|
-
|
-
|
8,295
|
||||||||||||
Municipal securities
|
692,205
|
18,112
|
(538
|
)
|
709,779
|
|||||||||||
Corporate bonds
|
186,085
|
9,724
|
(239
|
)
|
195,570
|
|||||||||||
Residential mortgage-backed securities
|
75,373
|
1,298
|
-
|
76,671
|
||||||||||||
Collateralized mortgage obligations
|
10,266
|
208
|
-
|
10,474
|
||||||||||||
Total fixed maturities available for sale
|
$
|
1,168,369
|
$
|
31,811
|
$
|
(778
|
)
|
$
|
1,199,402
|
|
2019
|
|||||||||||||||
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Estimated
Fair
Value
|
||||||||||||
|
||||||||||||||||
Fixed maturities held to maturity
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S.government instrumentalties
|
$
|
615
|
$
|
158
|
$
|
-
|
$
|
773
|
||||||||
Residential mortgage-backed securities
|
165
|
1
|
-
|
166
|
||||||||||||
Certificates of deposits
|
1,080
|
-
|
-
|
1,080
|
||||||||||||
Total
|
$
|
1,860
|
$
|
159
|
$
|
-
|
$
|
2,019
|
|
2018
|
|||||||||||||||
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Estimated
Fair
Value
|
||||||||||||
|
||||||||||||||||
Fixed maturities held to maturity
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S. government instrumentalties
|
$
|
617
|
$
|
125
|
$
|
-
|
$
|
742
|
||||||||
Residential mortgage-backed securities
|
190
|
2
|
-
|
192
|
||||||||||||
Certificates of deposits
|
1,685
|
-
|
-
|
1,685
|
||||||||||||
Total
|
$
|
2,492
|
$
|
127
|
$
|
-
|
$
|
2,619
|
|
2019
|
|||||||||||||||
|
Amortized
cost
|
Gross
unrealized
gains
|
Gross
unrealized
losses
|
Estimated
fair value
|
||||||||||||
Other invested assets - Alternative investments
|
$
|
97,575
|
$
|
3,721
|
$
|
(788
|
)
|
$
|
100,508
|
|
2018
|
|||||||||||||||
|
Amortized
cost
|
Gross
unrealized
gains
|
Gross
unrealized
losses
|
Estimated
fair value
|
||||||||||||
Other invested assets - Alternative investments
|
$
|
72,627
|
$
|
2,042
|
$
|
(654
|
)
|
$
|
74,015
|
|
2019
|
|||||||||||||||||||||||||||||||||||
|
Less than 12 months
|
12 months or longer
|
Total
|
|||||||||||||||||||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
|||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
Fixed maturities available for sale
|
||||||||||||||||||||||||||||||||||||
Municipal securities
|
$
|
10,656
|
$
|
(22
|
)
|
3
|
$
|
-
|
$
|
-
|
-
|
$
|
10,656
|
$
|
(22
|
)
|
3
|
|||||||||||||||||||
Corporate bonds
|
5,047
|
(74
|
)
|
1
|
-
|
-
|
-
|
5,047
|
(74
|
)
|
1
|
|||||||||||||||||||||||||
Residential mortgage-backed securities
|
79,902
|
(320
|
)
|
16
|
-
|
-
|
-
|
79,902
|
(320
|
)
|
16
|
|||||||||||||||||||||||||
Total fixed maturities
|
$
|
95,605
|
$
|
(416
|
)
|
20
|
$
|
-
|
$
|
-
|
-
|
$
|
95,605
|
$
|
(416
|
)
|
20
|
|||||||||||||||||||
Other invested assets - Alternative investments
|
$
|
24,437
|
$
|
(605
|
)
|
8
|
$
|
10,580
|
$
|
(183
|
)
|
1
|
$
|
35,017
|
$
|
(788
|
)
|
9
|
|
2018
|
|||||||||||||||||||||||||||||||||||
|
Less than 12 months
|
12 months or longer
|
Total
|
|||||||||||||||||||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
|||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
Fixed maturities available for sale
|
||||||||||||||||||||||||||||||||||||
Obligations of government- sponsored enterprises
|
$
|
1,469
|
$
|
(1
|
)
|
1
|
$
|
-
|
$
|
-
|
-
|
$
|
1,469
|
$
|
(1
|
)
|
1
|
|||||||||||||||||||
Municipal securities
|
62,328
|
(349
|
)
|
10
|
17,648
|
(189
|
)
|
3
|
79,976
|
(538
|
)
|
13
|
||||||||||||||||||||||||
Corporate bonds
|
52,539
|
(239
|
)
|
18
|
-
|
-
|
-
|
52,539
|
(239
|
)
|
18
|
|||||||||||||||||||||||||
Total fixed maturities
|
$
|
116,336
|
$
|
(589
|
)
|
29
|
$
|
17,648
|
$
|
(189
|
)
|
3
|
$
|
133,984
|
$
|
(778
|
)
|
32
|
||||||||||||||||||
Other invested assets - Alternative investments
|
$
|
7,399
|
$
|
(351
|
)
|
3
|
$
|
10,447
|
$
|
(303
|
)
|
2
|
$
|
17,846
|
$
|
(654
|
)
|
5
|
• |
Identification and evaluation of securities that have possible indications of other-than-temporary impairment, which includes an analysis of all investments with gross unrealized investment losses that represent 20% or more of their cost and all investments with an unrealized loss greater than $100;
|
• |
For any securities with a gross unrealized investment loss we might review and evaluate investee’s current financial condition, liquidity, near-term recovery prospects, implications of rating agency actions, the outlook for the business sectors in which the investee operates and other factors;
|
• |
Consideration of evidential matter, including an evaluation of factors or triggers that may or may not cause individual investments to qualify as having other-than-temporary impairments; and
|
• |
Determination of the status of each analyzed security as other-than-temporary or not, with documentation of the rationale for the decision.
|
|
Amortized
Cost
|
Estimated
Fair Value
|
||||||
|
||||||||
Securities available for sale
|
||||||||
Due in one year or less
|
$
|
5,420
|
$
|
5,539
|
||||
Due after one year through five years
|
441,969
|
459,711
|
||||||
Due after five years through ten years
|
241,081
|
257,294
|
||||||
Due after ten years
|
213,116
|
240,658
|
||||||
Residential mortgage-backed securities
|
262,783
|
270,536
|
||||||
Collateralized mortgage obligations
|
8,674
|
9,145
|
||||||
|
$
|
1,173,043
|
$
|
1,242,883
|
||||
Securities held to maturity
|
||||||||
Due in one year or less
|
$
|
1,080
|
$
|
1,080
|
||||
Due after five years through ten years
|
615
|
773
|
||||||
Residential mortgage-backed securities
|
165
|
166
|
||||||
|
$
|
1,860
|
$
|
2,019
|
4. |
Realized and Unrealized Gains
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Realized gains (losses)
|
||||||||||||
Fixed maturity securities:
|
||||||||||||
Securities available for sale
|
||||||||||||
Gross gains
|
$
|
3,844
|
$
|
3,730
|
$
|
1,460
|
||||||
Gross losses
|
(387
|
)
|
(18,627
|
)
|
(2,176
|
)
|
||||||
Total fixed maturity securities
|
3,457
|
(14,897
|
)
|
(716
|
)
|
|||||||
Equity investments:
|
||||||||||||
Gross gains
|
3,056
|
16,045
|
12,154
|
|||||||||
Gross losses
|
(1,669
|
)
|
(2,290
|
)
|
(558
|
)
|
||||||
Gross losses from other-than-temporary impairments
|
-
|
-
|
(49
|
)
|
||||||||
Total equity investments
|
1,387
|
13,755
|
11,547
|
|||||||||
Other invested assets:
|
||||||||||||
Gross gains
|
1,055
|
1,492
|
-
|
|||||||||
Gross losses
|
(56
|
)
|
(52
|
)
|
-
|
|||||||
Total other invested assets
|
999
|
1,440
|
-
|
|||||||||
Net realized gains on securities
|
$
|
5,843
|
$
|
298
|
$
|
10,831
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Changes in unrealized gains (losses)
|
||||||||||||
Recognized in accumulated other comprehensive income (loss)
|
||||||||||||
Fixed maturities – available for sale
|
$
|
38,807
|
$
|
(14,104
|
)
|
$
|
(2,203
|
)
|
||||
Other invested assets
|
1,545
|
1,073
|
-
|
|||||||||
Equity securities
|
-
|
-
|
20,514
|
|||||||||
Not recognized in the consolidated financial statements
|
||||||||||||
Fixed maturities – held to maturity
|
$
|
32
|
$
|
(29
|
)
|
$
|
(20
|
)
|
5. |
Net Investment Income
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Fixed maturities
|
$
|
42,005
|
$
|
43,873
|
$
|
38,414
|
||||||
Equity securities
|
12,453
|
12,261
|
10,728
|
|||||||||
Other invested assets
|
3,436
|
1,679
|
-
|
|||||||||
Policy loans
|
761
|
754
|
709
|
|||||||||
Cash equivalents and interest-bearing deposits
|
1,602
|
1,407
|
798
|
|||||||||
Other
|
1,750
|
1,935
|
966
|
|||||||||
Total
|
$
|
62,007
|
$
|
61,909
|
$
|
51,615
|
6. |
Premium and Other Receivables, Net
|
|
2019
|
2018
|
||||||
|
||||||||
Premium
|
$
|
188,861
|
$
|
94,613
|
||||
Self-funded group receivables
|
28,672
|
31,184
|
||||||
FEHBP
|
13,894
|
14,030
|
||||||
Agent balances
|
30,784
|
30,224
|
||||||
Accrued interest
|
11,307
|
12,426
|
||||||
Reinsurance recoverable
|
239,767
|
399,202
|
||||||
Other
|
110,952
|
88,807
|
||||||
|
624,237
|
670,486
|
||||||
Less allowance for doubtful receivables:
|
||||||||
Premium
|
36,622
|
32,487
|
||||||
Other
|
19,923
|
9,555
|
||||||
|
56,545
|
42,042
|
||||||
Premium and other receivables, net
|
$
|
567,692
|
$
|
628,444
|
7. |
Deferred Policy Acquisition Costs and Value of Business Acquired
|
|
DPAC
|
VOBA
|
Total
|
|||||||||
|
||||||||||||
Balance, December 31, 2016
|
$
|
168,625
|
$
|
26,162
|
$
|
194,787
|
||||||
|
||||||||||||
Additions
|
48,701
|
-
|
48,701
|
|||||||||
VOBA interest at an average rate of 5.17%
|
-
|
1,253
|
1,253
|
|||||||||
Amortization
|
(39,605
|
)
|
(4,348
|
)
|
(43,953
|
)
|
||||||
Net change
|
9,096
|
(3,095
|
)
|
6,001
|
||||||||
Balance, December 31, 2017
|
177,721
|
23,067
|
200,788
|
|||||||||
|
||||||||||||
Additions
|
51,144
|
-
|
51,144
|
|||||||||
VOBA interest at an average rate of 5.11%
|
-
|
1,120
|
1,120
|
|||||||||
Amortization
|
(35,005
|
)
|
(2,888
|
)
|
(37,893
|
)
|
||||||
Net change
|
16,139
|
(1,768
|
)
|
14,371
|
||||||||
Balance, December 31, 2018
|
193,860
|
21,299
|
215,159
|
|||||||||
|
||||||||||||
Additions
|
59,399
|
-
|
59,399
|
|||||||||
VOBA interest at an average rate of 4.53%
|
-
|
1,031
|
1,031
|
|||||||||
Amortization
|
(37,496
|
)
|
(3,208
|
)
|
(40,704
|
)
|
||||||
Net change
|
21,903
|
(2,177
|
)
|
19,726
|
||||||||
Balance, December 31, 2019
|
$
|
215,763
|
$
|
19,122
|
$
|
234,885
|
Year ending December 31:
|
||||
2020
|
$
|
2,766
|
||
2021
|
1,996
|
|||
2022
|
1,773
|
|||
2023
|
1,575
|
|||
2024
|
1,407
|
8. |
Property and Equipment, Net
|
|
2019
|
2018
|
||||||
|
||||||||
Land
|
$
|
10,976
|
$
|
10,976
|
||||
Buildings and leasehold improvements
|
92,752
|
68,424
|
||||||
Office furniture and equipment
|
27,878
|
39,421
|
||||||
Computer equipment and software
|
133,922
|
137,183
|
||||||
Automobiles
|
761
|
795
|
||||||
|
266,289
|
256,799
|
||||||
Less accumulated depreciation and amortization
|
177,701
|
174,876
|
||||||
Property and equipment, net
|
$
|
88,588
|
$
|
81,923
|
9. |
Goodwill
|
10. |
Fair Value Measurements
|
Level 1 |
Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
|
Level 2 |
Inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data at the measurement date.
|
Level 3 |
Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.
|
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
|
||||||||
|
2019
|
2018
|
||||||
Balance as of January 1,
|
$
|
3,805
|
$
|
-
|
||||
Unrealized gain in other accumulated comprehensive income
|
154
|
-
|
||||||
Purchases
|
1,250
|
3,805
|
||||||
Balance as of December 31,
|
$
|
5,209
|
$
|
3,805
|
|
2019
|
|||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
|
||||||||||||||||
Fixed maturity securities available for sale
|
||||||||||||||||
Obligations of government-sponsored enterprises
|
$
|
-
|
$
|
17,686
|
$
|
-
|
$
|
17,686
|
||||||||
U.S. Treasury securities and obligations of U.S. government instrumentalities
|
107,009
|
-
|
-
|
107,009
|
||||||||||||
Municipal securities
|
-
|
629,764
|
-
|
629,764
|
||||||||||||
Corporate bonds
|
-
|
208,743
|
-
|
208,743
|
||||||||||||
Residential agency mortgage-backed securities
|
-
|
270,536
|
-
|
270,536
|
||||||||||||
Collaterized mortgage obligations
|
-
|
9,145
|
-
|
9,145
|
||||||||||||
Total fixed maturities
|
$
|
107,009
|
$
|
1,135,874
|
$
|
-
|
$
|
1,242,883
|
||||||||
|
||||||||||||||||
Equity investments
|
$
|
177,136
|
$
|
105,180
|
$
|
5,209
|
$
|
287,525
|
|
2018
|
|||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
|
||||||||||||||||
Fixed maturity securities available for sale
|
||||||||||||||||
Obligations of government-sponsored enterprises
|
$
|
-
|
$
|
21,589
|
$
|
-
|
$
|
21,589
|
||||||||
U.S. Treasury securities and obligations of U.S. government instrumentalities
|
177,024
|
-
|
-
|
177,024
|
||||||||||||
Obligations of the Commonwealth of Puerto Rico and its instrumentalities
|
-
|
8,295
|
-
|
8,295
|
||||||||||||
Municipal securities
|
-
|
709,779
|
-
|
709,779
|
||||||||||||
Corporate bonds
|
-
|
195,570
|
-
|
195,570
|
||||||||||||
Residential agency mortgage-backed securities
|
-
|
76,671
|
-
|
76,671
|
||||||||||||
Collaterized mortgage obligations
|
-
|
10,474
|
-
|
10,474
|
||||||||||||
Total fixed maturities
|
$
|
177,024
|
$
|
1,022,378
|
$
|
-
|
$
|
1,199,402
|
||||||||
|
||||||||||||||||
Equity investments
|
$
|
147,348
|
$
|
128,011
|
$
|
3,805
|
$
|
279,164
|
11. |
Claim Liabilities and Claim Adjustment Expenses
|
|
2019
|
|||||||||||
|
Managed Care
|
Other Business Segments *
|
Consolidated
|
|||||||||
|
||||||||||||
Claim liabilities at beginning of year
|
$
|
394,226
|
$
|
542,563
|
$
|
936,789
|
||||||
Reinsurance recoverable on claim liabilities
|
-
|
(315,543
|
)
|
(315,543
|
)
|
|||||||
Net claim liabilities at beginning of year
|
394,226
|
227,020
|
621,246
|
|||||||||
Claims incurred
|
||||||||||||
Current period insured events
|
2,556,027
|
110,513
|
2,666,540
|
|||||||||
Prior period insured events
|
(29,344
|
)
|
(5,191
|
)
|
(34,535
|
)
|
||||||
Total
|
2,526,683
|
105,322
|
2,632,005
|
|||||||||
Payments of losses and loss-adjustment expenses
|
||||||||||||
Current period insured events
|
2,293,251
|
61,966
|
2,355,217
|
|||||||||
Prior period insured events
|
286,381
|
39,412
|
325,793
|
|||||||||
Total
|
2,579,632
|
101,378
|
2,681,010
|
|||||||||
Net claim liabilities at end of year
|
341,277
|
230,964
|
572,241
|
|||||||||
Reinsurance recoverable on claim liabilities
|
-
|
137,017
|
137,017
|
|||||||||
Claim liabilities at end of year
|
$
|
341,277
|
$
|
367,981
|
$
|
709,258
|
|
2018
|
|||||||||||
|
Managed Care
|
Other Business Segments *
|
Consolidated
|
|||||||||
|
||||||||||||
Claim liabilities at beginning of year
|
$
|
367,357
|
$
|
739,519
|
$
|
1,106,876
|
||||||
Reinsurance recoverable on claim liabilities
|
-
|
(633,099
|
)
|
(633,099
|
)
|
|||||||
Net claim liabilities at beginning of year
|
367,357
|
106,420
|
473,777
|
|||||||||
Claims incurred
|
||||||||||||
Current period insured events
|
2,308,516
|
103,368
|
2,411,884
|
|||||||||
Prior period insured events
|
(36,015
|
)
|
120,961
|
84,946
|
||||||||
Total
|
2,272,501
|
224,329
|
2,496,830
|
|||||||||
Payments of losses and loss-adjustment expenses
|
||||||||||||
Current period insured events
|
1,982,372
|
57,260
|
2,039,632
|
|||||||||
Prior period insured events
|
263,260
|
46,469
|
309,729
|
|||||||||
Total
|
2,245,632
|
103,729
|
2,349,361
|
|||||||||
Net claim liabilities at end of year
|
394,226
|
227,020
|
621,246
|
|||||||||
Reinsurance recoverable on claim liabilities
|
-
|
315,543
|
315,543
|
|||||||||
Claim liabilities at end of year
|
$
|
394,226
|
$
|
542,563
|
$
|
936,789
|
|
2017
|
|||||||||||
|
Managed Care
|
Other Business Segments *
|
Consolidated
|
|||||||||
|
||||||||||||
Claim liabilities at beginning of year
|
$
|
349,047
|
$
|
138,896
|
$
|
487,943
|
||||||
Reinsurance recoverable on claim liabilities
|
-
|
(38,998
|
)
|
(38,998
|
)
|
|||||||
Net claim liabilities at beginning of year
|
349,047
|
99,898
|
448,945
|
|||||||||
Claims incurred
|
||||||||||||
Current period insured events
|
2,231,052
|
118,012
|
2,349,064
|
|||||||||
Prior period insured events
|
(12,782
|
)
|
(8,975
|
)
|
(21,757
|
)
|
||||||
Total
|
2,218,270
|
109,037
|
2,327,307
|
|||||||||
Payments of losses and loss-adjustment expenses
|
||||||||||||
Current period insured events
|
1,940,410
|
64,051
|
2,004,461
|
|||||||||
Prior period insured events
|
259,550
|
38,536
|
298,086
|
|||||||||
Total
|
2,199,960
|
102,587
|
2,302,547
|
|||||||||
Net claim liabilities at end of year
|
367,357
|
106,348
|
473,705
|
|||||||||
Reinsurance recoverable on claim liabilities
|
-
|
633,171
|
633,171
|
|||||||||
Claim liabilities at end of year
|
$
|
367,357
|
$
|
739,519
|
$
|
1,106,876
|
* |
Other Business Segments include the Life Insurance and Property and Casualty segments, as well as intersegment eliminations.
|
|
||||||||||||||||
Incurred Claims and Allocated Claim
Adjustment Expenses, Net of Reinsurance
|
As of December 31, 2019
|
|||||||||||||||
Incurred Year
|
||||||||||||||||
(in thousands)
|
||||||||||||||||
(unaudited)
2018
|
2019
|
Total of IBNR Liabilities
Plus Expected
Development on
Reported Claims
|
Cumulative
Number of
Reported Claims
|
|||||||||||||
2018
|
$
|
2,308,518
|
$
|
2,292,293
|
$
|
33,699
|
17,652
|
|||||||||
2019
|
2,556,027
|
262,776
|
20,795
|
|||||||||||||
|
Total
|
$
|
4,848,320
|
|
||||||||
Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
||||||||
|
||||||||
Incurred Year
|
(unaudited)
2018
|
2019
|
||||||
2018
|
$
|
1,982,374
|
$
|
2,258,594
|
||||
2019
|
2,293,251
|
|||||||
|
Total
|
$
|
4,551,845
|
|||||
All outstanding liabilities before 2018, net of reinsurance
|
44,802
|
|||||||
Liabilities for claims and claim adjustment expenses, net of reinsurance
|
$
|
341,277
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
As of December 31, 2019
|
|||||||||||||||||||||||||||||||||||||||||||||||
Incurred Year
|
Incurred amount
|
Total of IBNR Plus
Expected Development
on Reported Claims
|
Cumulative Number
of reported claims
|
|||||||||||||||||||||||||||||||||||||||||||||
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
||||||||||||||||||||||||||||||||||||||||
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
2019
|
|||||||||||||||||||||||||||||||||||||||
2010
|
$
|
54,226
|
$
|
54,090
|
$
|
55,266
|
$
|
56,400
|
$
|
57,115
|
$
|
57,386
|
$
|
57,242
|
$
|
56,960
|
$
|
56,981
|
$
|
57,025
|
$
|
115
|
19,712
|
|||||||||||||||||||||||||
2011
|
51,315
|
50,287
|
51,105
|
50,776
|
51,895
|
52,099
|
51,729
|
51,684
|
51,771
|
110
|
20,779
|
|||||||||||||||||||||||||||||||||||||
2012
|
49,040
|
49,856
|
48,900
|
49,817
|
48,945
|
48,186
|
47,731
|
47,725
|
344
|
21,243
|
||||||||||||||||||||||||||||||||||||||
2013
|
52,343
|
51,030
|
49,606
|
49,168
|
48,229
|
47,550
|
47,104
|
586
|
20,904
|
|||||||||||||||||||||||||||||||||||||||
2014
|
48,430
|
45,410
|
43,707
|
42,547
|
41,457
|
41,147
|
591
|
19,106
|
||||||||||||||||||||||||||||||||||||||||
2015
|
45,067
|
40,175
|
37,271
|
35,505
|
34,889
|
796
|
18,041
|
|||||||||||||||||||||||||||||||||||||||||
2016
|
48,127
|
44,294
|
41,168
|
39,488
|
1,397
|
20,863
|
||||||||||||||||||||||||||||||||||||||||||
2017
|
60,694
|
187,376
|
189,162
|
6,264
|
39,368
|
|||||||||||||||||||||||||||||||||||||||||||
2018
|
40,619
|
37,603
|
5,894
|
16,299
|
||||||||||||||||||||||||||||||||||||||||||||
2019
|
43,589
|
18,808
|
9,166
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Total
|
$
|
589,503
|
Cumulative Paid claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||||||||||||
Incurred Year
|
||||||||||||||||||||||||||||||||||||||||
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
|||||||||||||||||||||||||||||||
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
2019
|
||||||||||||||||||||||||||||||
2010
|
$
|
27,118
|
$
|
38,964
|
$
|
45,409
|
$
|
49,808
|
$
|
52,890
|
$
|
54,027
|
$
|
54,996
|
$
|
55,715
|
$
|
56,253
|
$
|
56,428
|
||||||||||||||||||||
2011
|
24,534
|
34,835
|
41,606
|
44,996
|
47,908
|
49,598
|
50,457
|
50,761
|
51,127
|
|||||||||||||||||||||||||||||||
2012
|
22,677
|
33,620
|
40,406
|
43,663
|
45,607
|
46,094
|
46,441
|
46,625
|
||||||||||||||||||||||||||||||||
2013
|
21,376
|
33,249
|
38,979
|
42,840
|
44,252
|
45,234
|
45,502
|
|||||||||||||||||||||||||||||||||
2014
|
18,752
|
28,657
|
33,809
|
36,875
|
37,857
|
38,773
|
||||||||||||||||||||||||||||||||||
2015
|
17,063
|
24,935
|
28,040
|
30,729
|
32,188
|
|||||||||||||||||||||||||||||||||||
2016
|
20,099
|
28,996
|
32,820
|
34,546
|
||||||||||||||||||||||||||||||||||||
2017
|
28,414
|
41,855
|
48,574
|
|||||||||||||||||||||||||||||||||||||
2018
|
16,555
|
24,402
|
||||||||||||||||||||||||||||||||||||||
2019
|
16,305
|
|||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
$
|
394,470
|
||||||||||||||||||||||||||||||||||||||
|
All outstanding liabilities before 2010, net of reinsurance
|
1,996
|
||||||||||||||||||||||||||||||||||||||
|
Liabilities for claims and claims adjustment expenses, net of reinsurance
|
$
|
197,029
|
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
2019
|
Average
|
43.0%
|
20.7%
|
10.7%
|
7.0%
|
4.1%
|
2.1%
|
1.2%
|
0.7%
|
0.8%
|
0.3%
|
|
As of December 31, 2019
|
|
|
Net outstanding liabilities
|
|
Managed Care
|
$341,277
|
Property and Casualty
|
197,029
|
Liabilities for unpaid claims and claim adjustment expenses, net of reinsurance
|
538,306
|
|
|
Reinsurance recoverable on unpaid claims - Property and Casualty
|
124,990
|
|
|
Insurance lines other than short-duration
|
47,095
|
Intersegment elimination
|
(1,133)
|
Total gross liability for unpaid claims and claim adjustment expense
|
$709,258
|
12. |
Federal Employees’ Health Benefits (FEHBP) and Federal Employees’ (FEP) Programs
|
13. |
Borrowings
|
|
2019
|
2018
|
||||||
|
||||||||
Secured loan payable of $11,187, payable in monthly installments of $137 through October 1, 2023, plus interest at a rate reset periodically of 100 basis points over selected LIBOR maturity (which was 2.70% at December 31, 2019).
|
$
|
6,267
|
$
|
7,907
|
||||
Secured loan payable of $20,150, payable in monthly installments of $84 through January 1, 2024, plus interest at a rate reset periodically of 275 basis points over selected LIBOR maturity (which was 4.84% at December 31, 2019).
|
17,211
|
18,218
|
||||||
Secured loan payable of $4,116, payable in monthly installments of $49 through January 1, 2024, plus interest at a rate reset periodically of 325 basis points over selected LIBOR maturity (which was 5.34% at December 31, 2019).
|
2,401
|
2,989
|
||||||
Total borrowings
|
25,879
|
29,114
|
||||||
|
||||||||
Less: unamortized debt issuance costs
|
185
|
231
|
||||||
|
$
|
25,694
|
$
|
28,883
|
Year ending December 31
|
||||
2020
|
$
|
3,236
|
||
2021
|
3,236
|
|||
2022
|
3,236
|
|||
2023
|
2,942
|
|||
2024
|
13,229
|
|||
|
$
|
25,879
|
• |
In August 2019, TSS and TSV became members of the FHLBNY, which provides access to collateralized advances. The borrowing capacity of TSS and TSV is up to 30% of their admitted assets as disclosed in the most recent filing to the Commissioner of Insurance but is constrained by the amount of collateral held at the FHLBNY (see Note 3). As of December 31, 2019, the borrowing capacity is approximately $82,200 for TSS and $48,900 for TSV. The outstanding balance as of December 31, 2019 for TSS and TSV is $25,000 and $29,000, respectively. The average interest rate of the outstanding balance as of December 31, 2019 is 1.79%.
|
• |
As of December 31, 2019, TSS has $60,000 of available credit under repurchase agreements with broker-dealers, which are short term borrowing facilities using securities as collateral. There are no outstanding short-term borrowings under these facilities as of December 31, 2019.
|
• |
TSA has a $10,000 revolving loan agreement with a commercial bank in Puerto Rico. This line of credit has an interest rate of 30-day LIBOR plus 25 basis points and contains certain financial and non-financial covenants that are customary for this type of facility. This line of credit matures on April 30, 2020 and has no outstanding balance as of December 31, 2019.
|
14. |
Reinsurance Activity
|
Premiums Earned
|
Claims Incurred(1)
|
|||||||||||||||||||||||
|
2019
|
2018
|
2017
|
2019
|
2018
|
2017
|
||||||||||||||||||
|
||||||||||||||||||||||||
Gross
|
$
|
3,316,802
|
$
|
3,009,830
|
$
|
2,893,765
|
$
|
2,645,599
|
$
|
2,657,639
|
$
|
3,010,728
|
||||||||||||
Ceded
|
(66,320
|
)
|
(73,591
|
)
|
(71,295
|
)
|
(15,924
|
)
|
(163,898
|
)
|
(687,520
|
)
|
||||||||||||
Assumed
|
2,398
|
2,352
|
4,462
|
2,330
|
3,089
|
4,099
|
||||||||||||||||||
Net
|
$
|
3,252,880
|
$
|
2,938,591
|
$
|
2,826,932
|
$
|
2,632,005
|
$
|
2,496,830
|
$
|
2,327,307
|
(1) |
The claims incurred disclosed in this table exclude the portion of the change in the liability for future policy benefits amounting to $34,251, $30,783, and $25,794 that is included within the consolidated claims incurred during the years ended December 31, 2019, 2018 and 2017, respectively.
|
• |
For group policies, 80% of the claims up to a maximum of $800 (80% of $1,000), per person, per life. For other group policies with other options, the agreement covers 80% of the claims up to a maximum of $400 (80% of $500), per person, per life, or 80% of the claims up to a maximum of $200 (80% of $250), per person, per life.
|
• |
For policies provided to the active and retired employees of the Commonwealth of Puerto Rico and its instrumentalities, the treaty covers 100% of the claims up to a maximum of $1,000 per person, per life with major medical coverage, only if the covered person uses providers that are members of TSS network.
|
• |
For policies provided to the municipalities of Puerto Rico, the treaty covers 100% of the claims up to a maximum of $250, per person, per life, with plans with lifetime limits and all other plans 100% of the claims up to a maximum of $1,000, per person, per life.
|
• |
Casualty excess of loss treaty provides reinsurance for losses up to $20,000, subject to a retention of $225.
|
• |
Medical malpractice excess of loss treaty provides reinsurance for losses up to $3,000, subject to a retention of $150.
|
• |
Property reinsurance treaty includes proportional cessions and a per risk excess of loss contract limiting losses to $375 in $30,000 risks.
|
• |
Catastrophe protection is purchased limiting losses to $5,000 per event with losses up to approximately $775,000. After this, the retention of $24,500 from the next $70,000, for a total protection of $815,000 in an $845,000 event.
|
• |
Facultative pro rata agreements for the long‑term disability insurance, reinsuring 65% of the risk.
|
• |
Several reinsurance agreements, mostly on an excess of loss basis up to a maximum retention of $50.
|
• |
Excess of loss agreement for the major medical business in Costa Rica reinsuring 100% of all claims over $25.
|
15. |
Income Taxes
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Current income tax expense
|
$
|
35,714
|
$
|
2,212
|
$
|
34,412
|
||||||
Deferred income tax expense (benefit)
|
3,661
|
(32,078
|
)
|
(9,916
|
)
|
|||||||
Total income tax expense (benefit)
|
$
|
39,375
|
$
|
(29,866
|
)
|
$
|
24,496
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Income (loss) before taxes
|
$
|
132,252
|
$
|
(93,172
|
)
|
$
|
78,977
|
|||||
Statutory tax rate
|
37.50
|
%
|
39.00
|
%
|
39.00
|
%
|
||||||
Income tax expense (benefit) at statutory rate
|
49,595
|
(36,337
|
)
|
30,801
|
||||||||
(Decrease) increase in taxes resulting from:
|
||||||||||||
Exempt income, net
|
-
|
(2,330
|
)
|
(3,853
|
)
|
|||||||
Effect of taxing life insurance operations as a qualified domestic life insurance company instead of as a regular corporation
|
(4,823
|
)
|
(3,445
|
)
|
(4,871
|
)
|
||||||
Effect of taxing capital gains at a preferential rate
|
(6,290
|
)
|
4,819
|
(2,116
|
)
|
|||||||
Adjustment to deferred tax assets and liabilities for changes in effective tax rates
|
-
|
9,217
|
(120
|
)
|
||||||||
Other adjustments to deferred tax assets and liabilities
|
(549
|
)
|
(43
|
)
|
836
|
|||||||
Effect of extraordinary dividend distribution from the JUA Association - reported net of taxes in other income
|
(55
|
)
|
-
|
(922
|
)
|
|||||||
Charges against the catastrophe loss reserve
|
-
|
-
|
1,567
|
|||||||||
Allowance for doubtful receivables recapture
|
-
|
-
|
2,688
|
|||||||||
Effect of net operating loss limitations
|
1,239
|
-
|
-
|
|||||||||
Tax credit benefit
|
(62
|
)
|
(306
|
)
|
(555
|
)
|
||||||
Tax returns to provision true up
|
36
|
(798
|
)
|
363
|
||||||||
Subtotal
|
(10,504
|
)
|
7,114
|
(6,983
|
)
|
|||||||
Other permanent disallowances, net:
|
||||||||||||
Other
|
37
|
(229
|
)
|
50
|
||||||||
Other adjustments
|
247
|
(414
|
)
|
628
|
||||||||
Total income tax expense (benefit)
|
$
|
39,375
|
$
|
(29,866
|
)
|
$
|
24,496
|
|
2019
|
2018
|
||||||
|
||||||||
Deferred tax assets
|
||||||||
Allowance for doubtful receivables
|
$
|
18,882
|
$
|
14,092
|
||||
Liability for pension benefits
|
15,378
|
12,846
|
||||||
Postretirement benefits
|
415
|
527
|
||||||
Deferred compensation
|
2,187
|
2,202
|
||||||
Accumulated depreciation
|
920
|
979
|
||||||
Impairment loss on investments
|
522
|
765
|
||||||
Contingency reserves
|
4,063
|
75
|
||||||
Share-based compensation
|
8,086
|
5,587
|
||||||
Alternative minimum income tax credit
|
3,432
|
2,627
|
||||||
Purchased tax credits
|
458
|
1,229
|
||||||
Net operating loss
|
51,246
|
60,731
|
||||||
Reinsurance agreement
|
9,375
|
9,375
|
||||||
Accrued liabilities
|
5,599
|
4,292
|
||||||
Difference in tax basis of investments portfolio
|
77
|
320
|
||||||
Other
|
1,349
|
188
|
||||||
Gross deferred tax assets
|
121,989
|
115,835
|
||||||
Less: valuation allowance
|
(6,705
|
)
|
(9,867
|
)
|
||||
Deferred tax assets
|
115,284
|
105,968
|
||||||
|
||||||||
Deferred tax liabilities
|
||||||||
Deferred policy acquisition costs
|
(8,413
|
)
|
(6,382
|
)
|
||||
Catastrophe loss reserve
|
(13,014
|
)
|
(12,385
|
)
|
||||
Unrealized gain on securities available for sale
|
(14,965
|
)
|
(6,781
|
)
|
||||
Unrealized gain on equity investments
|
(9,091
|
)
|
(2,773
|
)
|
||||
Unamortized debt issue costs
|
(69
|
)
|
(87
|
)
|
||||
Intangible asset
|
(669
|
)
|
(909
|
)
|
||||
Employee benefits plan
|
(2,026
|
)
|
(886
|
)
|
||||
Gross deferred tax liabilities
|
(48,247
|
)
|
(30,203
|
)
|
||||
Net deferred tax asset
|
$
|
67,037
|
$
|
75,765
|
16. |
Pension Plans
|
|
2019
|
2018
|
||||||
|
||||||||
Change in benefit obligation
|
||||||||
Benefit obligation at beginning of year
|
$
|
159,477
|
$
|
185,052
|
||||
Interest cost
|
6,992
|
6,853
|
||||||
Benefit payments
|
(9,672
|
)
|
(4,466
|
)
|
||||
Actuarial loss (gain)
|
33,758
|
(18,114
|
)
|
|||||
Settlements
|
-
|
(9,848
|
)
|
|||||
Benefit obligation at end of year
|
$
|
190,555
|
$
|
159,477
|
||||
Accumulated benefit obligation at end of year
|
$
|
190,555
|
$
|
159,477
|
||||
Change in fair value of plan assets
|
||||||||
Fair value of plan assets at beginning of year
|
$
|
134,957
|
$
|
158,879
|
||||
Actual return on assets
|
36,273
|
(11,608
|
)
|
|||||
Employer contributions
|
2,000
|
2,000
|
||||||
Settlements
|
-
|
(9,848
|
)
|
|||||
Benefit payments
|
(9,672
|
)
|
(4,466
|
)
|
||||
Fair value of plan assets at end of year
|
$
|
163,558
|
$
|
134,957
|
||||
Funded status at end of year
|
$
|
(26,997
|
)
|
$
|
(24,520
|
)
|
|
2019
|
2018
|
||||||
|
||||||||
Pension liability
|
$
|
26,997
|
$
|
24,520
|
||||
Net actuarial loss recognized in accumulated other comprehensive loss, net of a deferred tax of $12,692 and $10,469 in 2019 and 2018, respectively
|
27,907
|
23,691
|
|
2019
|
2018
|
||||||
|
||||||||
Discount rate
|
3.25
|
%
|
4.50
|
%
|
||||
Expected return on plan assets
|
6.25
|
%
|
6.50
|
%
|
||||
Rate of compensation increase
|
N/A
|
N/A
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Components of net periodic benefit cost
|
||||||||||||
Service cost
|
$
|
-
|
$
|
-
|
$
|
223
|
||||||
Interest cost
|
6,992
|
6,853
|
7,186
|
|||||||||
Expected return on plan assets
|
(8,835
|
)
|
(9,020
|
)
|
(8,740
|
)
|
||||||
Actuarial loss
|
392
|
961
|
369
|
|||||||||
Settlement loss
|
-
|
2,110
|
-
|
|||||||||
Net periodic benefit (income) cost
|
$
|
(1,451
|
)
|
$
|
904
|
$
|
(962
|
)
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Discount rate
|
4.50
|
%
|
3.75
|
%
|
4.50
|
%
|
||||||
Expected return on plan assets
|
6.50
|
%
|
6.50
|
%
|
6.50
|
%
|
||||||
Rate of compensation increase
|
N/A
|
N/A
|
N/A
|
|
2019
|
|||||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
NAV
|
|||||||||||||||
|
||||||||||||||||||||
Government obligations
|
$
|
-
|
$
|
6,782
|
$
|
-
|
$
|
6,782
|
$
|
-
|
||||||||||
Non-agency backed securities
|
-
|
656
|
-
|
656
|
-
|
|||||||||||||||
Corporate obligations
|
-
|
9,353
|
-
|
9,353
|
-
|
|||||||||||||||
Limited Liability Corporations
|
-
|
-
|
-
|
-
|
126,989
|
|||||||||||||||
Real estate
|
-
|
-
|
-
|
-
|
6,720
|
|||||||||||||||
Registered investments
|
3,754
|
382
|
-
|
4,136
|
-
|
|||||||||||||||
Common/Collective trusts
|
-
|
7,527
|
-
|
7,527
|
-
|
|||||||||||||||
Common stocks
|
1,885
|
-
|
-
|
1,885
|
-
|
|||||||||||||||
Preferred stocks
|
-
|
14
|
-
|
14
|
-
|
|||||||||||||||
Interest-bearing cash
|
300
|
-
|
-
|
300
|
-
|
|||||||||||||||
|
$
|
5,939
|
$
|
24,714
|
$
|
-
|
$
|
30,653
|
$
|
133,709
|
|
2018
|
|||||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
NAV
|
|||||||||||||||
|
||||||||||||||||||||
Government obligations
|
$
|
-
|
$
|
6,856
|
$
|
-
|
$
|
6,856
|
$
|
-
|
||||||||||
Non-agency backed securities
|
-
|
759
|
-
|
759
|
-
|
|||||||||||||||
Corporate obligations
|
-
|
10,490
|
-
|
10,490
|
-
|
|||||||||||||||
Limited Liability Corporations
|
-
|
-
|
-
|
-
|
97,660
|
|||||||||||||||
Real estate
|
-
|
-
|
-
|
-
|
7,975
|
|||||||||||||||
Registered investments
|
2,328
|
1,610
|
-
|
3,938
|
-
|
|||||||||||||||
Common/Collective trusts
|
-
|
4,231
|
-
|
4,231
|
1,898
|
|||||||||||||||
Hedge funds
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||
Common stocks
|
1,566
|
-
|
-
|
1,566
|
-
|
|||||||||||||||
Preferred stocks
|
6
|
23
|
-
|
29
|
-
|
|||||||||||||||
Forward foreign currency contracts
|
-
|
42
|
-
|
42
|
-
|
|||||||||||||||
Interest-bearing cash
|
700
|
-
|
-
|
700
|
-
|
|||||||||||||||
Derivatives
|
-
|
44
|
-
|
44
|
-
|
|||||||||||||||
|
$
|
4,600
|
$
|
24,055
|
$
|
-
|
$
|
28,655
|
$
|
107,533
|
• |
Increasing risk is rewarded with compensating returns over time, and therefore, prudent risk taking is justifiable for long-term investors
|
• |
Risk can be controlled through diversification of asset classes and investment approaches, as well as diversification of individual securities
|
• |
Risk is reduced by time, and over time the relative performance of different asset classes is reasonably consistent. Over the long-term, equity investments have provided and should continue to provide superior returns over other security types. Fixed-income securities can dampen volatility and provide liquidity in periods of depressed economic activity. Lengthening duration of fixed income securities may reduce surplus volatility.
|
• |
The strategic or long-term allocation of assets among various asset classes is an important driver of long‑term returns.
|
• |
Relative performance of various asset classes is unpredictable in the short‑term and attempts to shift tactically between asset classes are unlikely to be rewarded.
|
• |
To earn the maximum return that can be realistically achieved in the markets over the long‑term at a specified and controlled level of risk in order to minimize future contributions.
|
• |
To invest assets with consideration of the liability characteristics in order to better align assets and liabilities.
|
• |
To invest the assets with the care, skill, and diligence that a prudent person acting in a like capacity would undertake. In the process, the Administration of the Trust has the objective of controlling the costs involved with administering and managing the investments of the National Retirement Trust.
|
Year ending December 31
|
||||
2020
|
$
|
10,531
|
||
2021
|
9,593
|
|||
2022
|
9,685
|
|||
2023
|
9,732
|
|||
2024
|
9,800
|
|||
2025 – 2029
|
51,688
|
17. |
Catastrophe Loss Reserve and Trust Fund
|
18. |
Stockholders’ Equity
|
a. |
Common Stock
|
b. |
Preferred Stock
|
c. |
Liquidity Requirements
|
d. |
Dividends
|
19. |
Stock Repurchase Programs
|
20. |
Comprehensive Income
|
|
Unrealized
Gains on
Securities
|
Liability
for Pension
Benefits
|
Accumulated
Other
Comprehensive
Income
|
|||||||||
|
||||||||||||
Beginning balance at December 31, 2018
|
$
|
27,308
|
$
|
(24,246
|
)
|
$
|
3,062
|
|||||
Net current period change
|
34,224
|
(4,468
|
)
|
29,756
|
||||||||
Reclassification adjustments for gains and losses reclassified in income
|
(3,702
|
)
|
247
|
(3,455
|
)
|
|||||||
Ending balance at December 31, 2019
|
$
|
57,830
|
$
|
(28,467
|
)
|
$
|
29,363
|
|
2019
|
|||||||||||
|
Before-Tax
Amount
|
Deferred Tax
(Expense)
Benefit
|
Net-of-Tax
Amount
|
|||||||||
|
||||||||||||
Unrealized holding gains on securities arising during the period
|
$
|
42,780
|
$
|
(8,556
|
)
|
$
|
34,224
|
|||||
Less reclassification adjustment for gains and losses realized in income
|
(4,456
|
)
|
754
|
(3,702
|
)
|
|||||||
Net change in unrealized gain
|
38,324
|
(7,802
|
)
|
30,522
|
||||||||
Liability for pension benefits:
|
||||||||||||
Reclassification adjustment for amortization of net losses from past experience and prior service costs
|
396
|
(149
|
)
|
247
|
||||||||
Net change arising from assumptions and plan changes and experience
|
(7,149
|
)
|
2,681
|
(4,468
|
)
|
|||||||
Net change in liability for pension benefits
|
(6,753
|
)
|
2,532
|
(4,221
|
)
|
|||||||
Net current period change
|
$
|
31,571
|
$
|
(5,270
|
)
|
$
|
26,301
|
|
2018
|
|||||||||||
|
Before-Tax
Amount
|
Deferred Tax
(Expense)
Benefit
|
Net-of-Tax
Amount
|
|||||||||
|
||||||||||||
Unrealized holding gains on securities arising during the period
|
$
|
(24,375
|
)
|
$
|
4,875
|
$
|
(19,500
|
)
|
||||
Less reclassification adjustment for gains and losses realized in income
|
13,457
|
(3,005
|
)
|
10,452
|
||||||||
Net change in unrealized gain
|
(10,918
|
)
|
1,870
|
(9,048
|
)
|
|||||||
Liability for pension benefits:
|
||||||||||||
Reclassification adjustment for amortization of net losses from past experience and prior service costs
|
(995
|
)
|
373
|
(622
|
)
|
|||||||
Net change arising from assumptions and plan changes and experience
|
2,190
|
(830
|
)
|
1,360
|
||||||||
Net change in liability for pension benefits
|
1,195
|
(457
|
)
|
738
|
||||||||
Net current period change
|
$
|
(9,723
|
)
|
$
|
1,413
|
$
|
(8,310
|
)
|
|
2017
|
|||||||||||
|
Before-Tax
Amount
|
Deferred Tax
(Expense)
Benefit
|
Net-of-Tax
Amount
|
|||||||||
|
||||||||||||
Unrealized holding gains on securities arising during the period
|
$
|
28,544
|
$
|
(5,708
|
)
|
$
|
22,836
|
|||||
Less reclassification adjustment for gains and losses realized in income
|
(10,831
|
)
|
1,862
|
(8,969
|
)
|
|||||||
Net change in unrealized gain
|
17,713
|
(3,846
|
)
|
13,867
|
||||||||
Liability for pension benefits:
|
||||||||||||
Reclassification adjustment for amortization of net losses from past experience and prior service costs
|
5
|
(2
|
)
|
3
|
||||||||
Net change arising from assumptions and plan changes and experience
|
(8,215
|
)
|
3,204
|
(5,011
|
)
|
|||||||
Net change in liability for pension benefits
|
(8,210
|
)
|
3,202
|
(5,008
|
)
|
|||||||
Net current period change
|
$
|
9,503
|
$
|
(644
|
)
|
$
|
8,859
|
|
Restricted Awards
|
Performance Awards
|
||||||||||||||
|
Number of
Shares
|
Weighted
Average
Fair
Value
|
Number of
Shares
|
Weighted
Average
Exercise
Price
|
||||||||||||
|
||||||||||||||||
Outstanding balance at January 1, 2019
|
205,873
|
$
|
24.67
|
559,838
|
$
|
21.86
|
||||||||||
Granted
|
221,342
|
24.53
|
282,293
|
24.82
|
||||||||||||
Lapsed
|
(113,230
|
)
|
25.83
|
(447,038
|
)
|
18.21
|
||||||||||
Forfeited (due to termination)
|
(5,598
|
)
|
23.90
|
(18,146
|
)
|
23.34
|
||||||||||
Quantity adjusted (due to performance payout more than 100%), net of forfeited
|
-
|
-
|
138,741
|
18.21
|
||||||||||||
Outstanding balance at December 31, 2019
|
308,387
|
$
|
24.16
|
515,688
|
$
|
25.60
|
22. |
Net Income Available to Stockholders and Basic Net Income per Share
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Numerator for earnings per share
|
||||||||||||
Net income (loss) attributable to TSM available to stockholders
|
$
|
92,894
|
$
|
(63,302
|
)
|
$
|
54,486
|
|||||
Denominator for basic earnings per share – Weighted average of common shares
|
23,318,742
|
22,975,385
|
23,996,503
|
|||||||||
Effect of dilutive securities
|
66,551
|
-
|
71,083
|
|||||||||
Denominator for diluted earnings per share
|
23,385,293
|
22,975,385
|
24,067,586
|
|||||||||
Basic net income (loss) per share attributable to TSM
|
$
|
3.98
|
$
|
(2.76
|
)
|
$
|
2.27
|
|||||
Diluted net income (loss) per share attributable to TSM
|
$
|
3.97
|
$
|
(2.76
|
)
|
$
|
2.26
|
23. |
Commitments
|
Year ending December 31
|
||||
2020
|
$
|
4,713
|
||
2021
|
3,790
|
|||
2022
|
3,200
|
|||
2023
|
2,171
|
|||
2024
|
1,710
|
|||
Thereafter
|
2,707
|
|||
Total
|
$
|
18,291
|
24. |
Contingencies
|
25. |
Statutory Accounting
|
(dollar amounts in millions)
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Net admitted assets
|
$
|
2,394
|
$
|
2,089
|
$
|
2,102
|
||||||
Capital and surplus
|
767
|
602
|
647
|
|||||||||
RBC requirement
|
546
|
312
|
301
|
|||||||||
Net income (loss)
|
68
|
(32
|
)
|
87
|
26. |
Supplementary Information on Cash Flow Activities
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Supplementary information
|
||||||||||||
Noncash transactions affecting cash flow activities
|
||||||||||||
Change in net unrealized (gain) loss on securities available for sale, including deferred income tax liability (asset) of $7,802, ($1,870), and $3,846 in 2019, 2018, and 2017, respectively
|
$
|
(30,522
|
)
|
$
|
9,048
|
$
|
(13,867
|
)
|
||||
Change in liability for pension benefits, and deferred income tax liability (asset) of ($2,532), $457, ($3,202), in 2019, 2018, and 2017, respectively
|
$
|
4,221
|
$
|
(738
|
)
|
$
|
5,008
|
|||||
Repurchase and retirement of common stock
|
$
|
(119
|
)
|
$
|
(748
|
)
|
$
|
(89
|
)
|
|||
Stock dividend
|
$
|
(24,655
|
)
|
$
|
-
|
$
|
-
|
|||||
Issuance of common stocks
|
$
|
1,200
|
$
|
-
|
$
|
-
|
||||||
Capitalization of lease right of use asset
|
$
|
10,438
|
$
|
-
|
$
|
-
|
||||||
Other
|
||||||||||||
Income taxes paid
|
$
|
3,147
|
$
|
8,978
|
$
|
10,363
|
||||||
Interest paid
|
$
|
7,672
|
$
|
6,903
|
$
|
6,794
|
27. |
Segment Information
|
• |
Managed Care segment – This segment is engaged in the sale of managed care products to the Commercial, Medicare and Medicaid market sectors. The Commercial accounts sector includes corporate accounts, U.S. federal government employees, individual accounts, local government employees, and Medicare supplement. The following represents a description of the major contracts by sector:
|
The segment is a qualified contractor to provide health coverage to federal government employees within Puerto Rico and the USVI. Earned premiums revenue related to this contract amounted to $161,716, $150,232 and $156,417 for the years ended December 31, 2019, 2018, and 2017, respectively (see Note 12).
|
Under its commercial business, the segment also provides health coverage to certain employees of the Commonwealth of Puerto Rico and its instrumentalities. Earned premium revenue related to such health plans amounted to $16,805, $24,186 and $28,149 for years ended December 31, 2019, 2018, and 2017, respectively.
|
The segment also participates in the Medicaid program to provide health coverage to medically indigent citizens in Puerto Rico, as defined by the laws of the government of Puerto Rico. Earned premium revenue related to this business amounted to $778,263, $776,038, and $751,393 for the years ended December 31, 2019, 2018, and 2017, respectively.
|
• |
Life Insurance segment – This segment offers primarily life and accident and health insurance coverage, and annuity products. The premiums for this segment are mainly subscribed through an internal sales force and a network of independent brokers and agents.
|
• |
Property and Casualty Insurance segment –The predominant insurance products of this segment are commercial package, commercial auto, and personal package. The premiums for this segment are originated through a network of independent insurance agents and brokers. Agents or general agencies collect the premiums from the insureds, which are subsequently remitted to the segment, net of commissions. Remittances are generally due 60 days after the closing date of the general agent’s account current.
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Operating revenues
|
||||||||||||
Managed care
|
||||||||||||
Premiums earned, net
|
$
|
2,985,600
|
$
|
2,687,773
|
$
|
2,588,692
|
||||||
Fee revenue
|
9,946
|
14,701
|
16,514
|
|||||||||
Intersegment premiums/fee revenue
|
6,269
|
5,690
|
6,362
|
|||||||||
Net investment income
|
23,468
|
23,827
|
16,659
|
|||||||||
Total managed care
|
3,025,283
|
2,731,991
|
2,628,227
|
|||||||||
Life
|
||||||||||||
Premiums earned, net
|
180,204
|
167,888
|
161,628
|
|||||||||
Intersegment premiums
|
1,987
|
668
|
218
|
|||||||||
Net investment income
|
27,323
|
25,658
|
24,819
|
|||||||||
Total life
|
209,514
|
194,214
|
186,665
|
|||||||||
Property and casualty
|
||||||||||||
Premiums earned, net
|
87,076
|
82,930
|
76,612
|
|||||||||
Intersegment premiums
|
613
|
613
|
613
|
|||||||||
Net investment income
|
9,773
|
10,800
|
9,489
|
|||||||||
Total property and casualty
|
97,462
|
94,343
|
86,714
|
|||||||||
Other segments*
|
||||||||||||
Intersegment service revenues
|
8,836
|
283
|
8,677
|
|||||||||
Operating revenues from external sources
|
8,553
|
5,794
|
3,763
|
|||||||||
Total other segments
|
17,389
|
6,077
|
12,440
|
|||||||||
Total business segments
|
3,349,648
|
3,026,625
|
2,914,046
|
|||||||||
TSM operating revenues from external sources
|
1,443
|
1,624
|
545
|
|||||||||
Elimination of intersegment premiums
|
(8,869
|
)
|
(6,971
|
)
|
(7,193
|
)
|
||||||
Elimination of intersegment service revenue
|
(8,836
|
)
|
(283
|
)
|
(8,677
|
)
|
||||||
Consolidated operating revenues
|
$
|
3,333,386
|
$
|
3,020,995
|
$
|
2,898,721
|
* |
Includes segments that are not required to be reported separately, primarily the data processing services organization and the health clinics.
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Operating income (loss)
|
||||||||||||
Managed care
|
$
|
61,907
|
$
|
26,468
|
$
|
55,040
|
||||||
Life
|
21,912
|
19,901
|
19,434
|
|||||||||
Property and casualty
|
14,492
|
(110,119
|
)
|
(6,034
|
)
|
|||||||
Other segments*
|
(3,054
|
)
|
8
|
(391
|
)
|
|||||||
Total business segments
|
95,257
|
(63,742
|
)
|
68,049
|
||||||||
TSM operating revenues from external sources
|
1,443
|
1,624
|
545
|
|||||||||
TSM unallocated operating expenses
|
(8,588
|
)
|
(8,815
|
)
|
(9,787
|
)
|
||||||
Elimination of TSM charges
|
9,612
|
9,600
|
9,600
|
|||||||||
Consolidated operating income (loss)
|
97,724
|
(61,333
|
)
|
68,407
|
||||||||
Consolidated net realized investment gains
|
5,843
|
298
|
10,831
|
|||||||||
Consolidated net unrealized investment gains (losses) on equity securities
|
32,151
|
(36,546
|
)
|
-
|
||||||||
Consolidated interest expense
|
(7,672
|
)
|
(6,903
|
)
|
(6,794
|
)
|
||||||
Consolidated other income, net
|
4,206
|
11,312
|
6,533
|
|||||||||
Consolidated income (loss) before taxes
|
$
|
132,252
|
$
|
(93,172
|
)
|
$
|
78,977
|
|
2019
|
2018
|
2017
|
|||||||||
Depreciation and amortization expense
|
||||||||||||
Managed care
|
$
|
11,527
|
$
|
10,525
|
$
|
10,007
|
||||||
Life
|
1,081
|
1,134
|
1,203
|
|||||||||
Property and casualty
|
385
|
384
|
528
|
|||||||||
Other segments*
|
910
|
705
|
673
|
|||||||||
Total business segments
|
13,903
|
12,748
|
12,411
|
|||||||||
TSM depreciation expense
|
697
|
787
|
787
|
|||||||||
Consolidated depreciation and amortization expense
|
$
|
14,600
|
$
|
13,535
|
$
|
13,198
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Assets
|
||||||||||||
Managed care
|
$
|
1,190,538
|
$
|
1,078,262
|
$
|
1,092,715
|
||||||
Life
|
981,370
|
863,470
|
853,289
|
|||||||||
Property and casualty
|
592,758
|
747,583
|
1,094,773
|
|||||||||
Other segments*
|
28,346
|
20,705
|
19,027
|
|||||||||
Total business segments
|
2,793,012
|
2,710,020
|
3,059,804
|
|||||||||
Unallocated amounts related to TSM
|
||||||||||||
Cash, cash equivalents, and investments
|
28,167
|
57,818
|
81,169
|
|||||||||
Property and equipment, net
|
25,623
|
21,733
|
22,257
|
|||||||||
Other assets
|
37,176
|
22,521
|
22,763
|
|||||||||
|
90,966
|
102,072
|
126,189
|
|||||||||
Elimination entries – intersegment receivables and others
|
(65,152
|
)
|
(51,844
|
)
|
(69,228
|
)
|
||||||
Consolidated total assets
|
$
|
2,818,826
|
$
|
2,760,248
|
$
|
3,116,765
|
|
2019
|
2018
|
2017
|
|||||||||
Significant noncash items
|
||||||||||||
Net change in unrealized gain (loss) on securities available for sale
|
||||||||||||
Managed care
|
$
|
9,687
|
$
|
2,585
|
$
|
3,932
|
||||||
Life
|
17,442
|
(11,285
|
)
|
7,142
|
||||||||
Property and casualty
|
3,023
|
(583
|
)
|
2,691
|
||||||||
Other segments*
|
-
|
-
|
-
|
|||||||||
Total business segments
|
30,152
|
(9,283
|
)
|
13,765
|
||||||||
Amount related to TSM
|
370
|
235
|
102
|
|||||||||
Consolidated net change in unrealized (loss) gain on securities available for sale
|
$
|
30,522
|
$
|
(9,048
|
)
|
$
|
13,867
|
* |
Includes segments that are not required to be reported separately, primarily the data processing services organization and the health clinics.
|
28. |
Subsequent Events
|
|
As of December 31,
|
|||||||
|
2019
|
2018
|
||||||
|
||||||||
Assets:
|
||||||||
Cash and cash equivalents
|
$
|
3,712
|
$
|
19,121
|
||||
Securities available for sale, at fair value:
|
||||||||
Equity Securities (cost of $5,853 in 2019 and $24,376 in 2018)
|
5,857
|
23,922
|
||||||
Other invested assets, measured at net asset value (amortized cost of $17,711 in 2019 and $14,352 in 2018)
|
18,598
|
14,775
|
||||||
Investment in subsidiaries
|
878,695
|
767,923
|
||||||
Notes receivable and accrued interest from subsidiaries
|
59,085
|
44,340
|
||||||
Due from subsidiaries
|
19,575
|
7,881
|
||||||
Deferred tax assets
|
20,701
|
17,821
|
||||||
Other assets
|
42,098
|
26,433
|
||||||
Total assets
|
$
|
1,048,321
|
$
|
922,216
|
||||
|
||||||||
Liabilities:
|
||||||||
Notes payable and accrued interest to subsidiary
|
18,965
|
18,096
|
||||||
Due to subsidiaries
|
1,531
|
5,564
|
||||||
Long-term borrowings
|
25,694
|
28,883
|
||||||
Liability for pension benefits
|
34,465
|
31,274
|
||||||
Other liabilities
|
23,801
|
16,415
|
||||||
Total liabilities
|
104,456
|
100,232
|
||||||
|
||||||||
Stockholders’ equity:
|
||||||||
Common stock, class A
|
-
|
951
|
||||||
Common stock, class B
|
23,800
|
21,980
|
||||||
Additional paid-in-capital
|
60,504
|
34,021
|
||||||
Retained earnings
|
830,198
|
761,970
|
||||||
Accumulated other comprehensive income, net
|
29,363
|
3,062
|
||||||
Total stockholders’ equity
|
943,865
|
821,984
|
||||||
Total liabilities and stockholders’ equity
|
$
|
1,048,321
|
$
|
922,216
|
|
2019
|
2018
|
2017
|
|||||||||
|
||||||||||||
Investment income
|
$
|
1,443
|
$
|
1,624
|
$
|
545
|
||||||
Net realized investment (gains) losses
|
(63
|
)
|
33
|
-
|
||||||||
Net unrealized investment gains (losses) on equity investments
|
459
|
(462
|
)
|
-
|
||||||||
Other revenues
|
11,613
|
11,778
|
10,836
|
|||||||||
Total revenues
|
13,452
|
12,973
|
11,381
|
|||||||||
|
||||||||||||
Operating expenses:
|
||||||||||||
General and administrative expenses
|
8,588
|
8,815
|
9,787
|
|||||||||
Interest expense
|
1,334
|
1,375
|
1,196
|
|||||||||
Total operating expenses
|
9,922
|
10,190
|
10,983
|
|||||||||
Income before income taxes
|
3,530
|
2,783
|
398
|
|||||||||
Income tax expense
|
7
|
344
|
295
|
|||||||||
Income from parent company
|
3,523
|
2,439
|
103
|
|||||||||
Equity in net income (loss) of subsidiaries
|
89,371
|
(65,741
|
)
|
54,383
|
||||||||
Net income (loss)
|
$
|
92,894
|
$
|
(63,302
|
)
|
$
|
54,486
|
|
2019
|
2018
|
2017
|
|||||||||
Net income (loss)
|
$
|
92,894
|
$
|
(63,302
|
)
|
$
|
54,486
|
|||||
Adjustment to reconcile net (loss) income to net cash provided by operating activities:
|
||||||||||||
Equity in net income of subsidiaries
|
(89,371
|
)
|
65,741
|
(54,383
|
)
|
|||||||
Net realized investment (losses) gains
|
63
|
(33
|
)
|
-
|
||||||||
Net unrealized investment (gain) losses on equity investments
|
(459
|
)
|
462
|
-
|
||||||||
Depreciation and amortization
|
871
|
961
|
880
|
|||||||||
Net amortization of investments
|
-
|
53
|
-
|
|||||||||
Shared- based compensation
|
11,605
|
3,357
|
7,076
|
|||||||||
Deferred income tax benefit
|
(438
|
)
|
(330
|
)
|
(33
|
)
|
||||||
Dividends received from subsidiaries
|
8,750
|
6,000
|
90,000
|
|||||||||
Return of investment due to closing of subsidiary
|
-
|
-
|
7,731
|
|||||||||
Changes in assets and liabilities:
|
||||||||||||
Accrued interest from subsidiaries, net
|
(1,876
|
)
|
(642
|
)
|
5,076
|
|||||||
Due from subsidiaries
|
(11,694
|
)
|
1,093
|
(3,672
|
)
|
|||||||
Other assets
|
(357
|
)
|
(99
|
)
|
1,917
|
|||||||
Due to subsidiaries
|
(4,033
|
)
|
5,498
|
(22,595
|
)
|
|||||||
Other liabilities
|
4,953
|
(3,680
|
)
|
1,339
|
||||||||
Net cash provided by operating activities
|
10,908
|
15,079
|
87,822
|
|||||||||
Cash flows from investing activities:
|
||||||||||||
Acquisition of investment in securities classified as available for sale
|
-
|
(18,007
|
)
|
-
|
||||||||
Acquisition of equity investments
|
(13,930
|
)
|
(11,856
|
)
|
(61,747
|
)
|
||||||
Acquisition of investment in other invested assets, measured at net asset value
|
(3,738
|
)
|
(10,862
|
)
|
-
|
|||||||
Capital contribution to subsidiaries
|
-
|
(12,189
|
)
|
-
|
||||||||
Proceeds from sale and maturities of investment in securities classified as available for sale
|
-
|
17,959
|
-
|
|||||||||
Proceeds from sales of other invested assets
|
377
|
-
|
-
|
|||||||||
Proceeds from sale of equity investments
|
32,389
|
47,506
|
1,126
|
|||||||||
Issuance of note receivable to subsidiary
|
(12,000
|
)
|
-
|
-
|
||||||||
Capital contribution in equity method investees
|
(11,418
|
)
|
-
|
-
|
||||||||
Net acquisition of property and equipment
|
(4,761
|
)
|
(437
|
)
|
(757
|
)
|
||||||
Net cash (used in) provided by investing activities
|
(13,081
|
)
|
12,114
|
(61,378
|
)
|
|||||||
Cash flow from financing activities:
|
||||||||||||
Repayments of long-term borrowings
|
(3,236
|
)
|
(3,236
|
)
|
(2,836
|
)
|
||||||
Repurchase of common stock
|
(9,989
|
)
|
(22,377
|
)
|
(20,220
|
)
|
||||||
Dividends paid
|
(11
|
)
|
-
|
-
|
||||||||
Net cash used in financing activities
|
(13,236
|
)
|
(25,613
|
)
|
(23,056
|
)
|
||||||
Net increase in cash and cash equivalents
|
(15,409
|
)
|
1,580
|
3,388
|
||||||||
Cash and cash equivalents, beginning of year
|
19,121
|
17,541
|
14,153
|
|||||||||
Cash and cash equivalents, end of year
|
$
|
3,712
|
$
|
19,121
|
$
|
17,541
|
|
2019
|
2018
|
||||||
|
||||||||
Secured loan payable of $11,187, payable in monthly installments of $137 through October 1, 2023, plus interest at a rate reset periodically of 100 basis points over selected LIBOR maturity (which was 2.70% at December 31, 2019).
|
$
|
6,267
|
$
|
7,907
|
||||
Secured loan payable of $20,150, payable in monthly installments of $84 through January 1, 2024, plus interest at a rate reset periodically of 275 basis points over selected LIBOR maturity (which was 4.84% at December 31, 2019).
|
17,211
|
18,218
|
||||||
Secured loan payable of $4,116, payable in monthly installments of $49 through January 1, 2024, plus interest at a rate reset periodically of 325 basis points over selected LIBOR maturity (which was 5.34% at December 31, 2019).
|
2,401
|
2,989
|
||||||
Total borrowings
|
25,879
|
29,114
|
||||||
|
||||||||
Less: unamortized debt issuance costs
|
185
|
231
|
||||||
|
$
|
25,694
|
$
|
28,883
|
Year ending December 31
|
||||
2020
|
$
|
3,236
|
||
2021
|
3,236
|
|||
2022
|
3,236
|
|||
2023
|
2,942
|
|||
2024
|
13,229
|
|||
|
$
|
25,879
|
|
2019
|
2018
|
2017
|
|||||||||
Rent charges to subsidiaries
|
$
|
7,809
|
$
|
7,874
|
$
|
7,807
|
||||||
Interest charged to subsidiaries on notes receivable
|
2,275
|
1,935
|
2,032
|
|||||||||
Interest charged from subsidiary on note payable
|
869
|
829
|
791
|
Segment
|
Deferred
Policy
Acquisition
Costs and Value
of Business
Acquired
|
Claim
Liabilities
|
Liability for
Future
Policy
Benefits
|
Unearned
Premiums
|
Other
Policy Claims
and Benefits
Payable
|
Premium
Revenue
|
Net
Investment
Income
|
Claims
Incurred
|
Amortization of
Deferred Policy
Acquisition
Costs and Value
of Business
Acquired
|
Other
Operating
Expenses
|
Net
Premiums
Written
|
|||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
2019
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
Managed care
|
$
|
-
|
$
|
341,277
|
$
|
-
|
$
|
2,188
|
$
|
-
|
$
|
2,987,466
|
$
|
23,468
|
$
|
2,526,682
|
$
|
-
|
$
|
436,694
|
$
|
2,987,466
|
||||||||||||||||||||||
Life insurance
|
212,345
|
47,095
|
386,017
|
10,889
|
-
|
182,191
|
27,323
|
105,889
|
14,911
|
66,802
|
182,191
|
|||||||||||||||||||||||||||||||||
Property and casualty insurance
|
22,434
|
322,018
|
-
|
80,224
|
-
|
87,689
|
9,773
|
39,548
|
22,742
|
20,679
|
98,164
|
|||||||||||||||||||||||||||||||||
Other non-reportable segments, parent company operations and net consolidating entries.
|
-
|
-
|
-
|
-
|
-
|
-
|
1,443
|
(5,863
|
)
|
-
|
7,578
|
-
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
Total
|
$
|
234,779
|
$
|
710,390
|
$
|
386,017
|
$
|
93,301
|
$
|
-
|
$
|
3,257,346
|
$
|
62,007
|
$
|
2,666,256
|
$
|
37,653
|
$
|
531,753
|
$
|
3,267,821
|
||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
2018
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
Managed care
|
$
|
-
|
$
|
394,226
|
$
|
-
|
$
|
2,418
|
$
|
-
|
$
|
2,689,082
|
$
|
23,827
|
$
|
2,272,501
|
$
|
-
|
$
|
433,022
|
$
|
2,689,082
|
||||||||||||||||||||||
Life insurance
|
198,140
|
46,157
|
361,495
|
9,490
|
-
|
168,556
|
25,658
|
99,048
|
11,017
|
64,248
|
168,556
|
|||||||||||||||||||||||||||||||||
Property and casualty insurance
|
17,019
|
496,876
|
-
|
71,082
|
-
|
83,543
|
10,800
|
159,942
|
25,756
|
18,764
|
79,472
|
|||||||||||||||||||||||||||||||||
Other non-reportable segments, parent company operations and net consolidating entries.
|
-
|
(470
|
)
|
-
|
-
|
-
|
(2,590
|
)
|
1,624
|
(3,878
|
)
|
-
|
1,908
|
-
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
Total
|
$
|
215,159
|
$
|
936,789
|
$
|
361,495
|
$
|
82,990
|
$
|
-
|
$
|
2,938,591
|
$
|
61,909
|
$
|
2,527,613
|
$
|
36,773
|
$
|
517,942
|
$
|
2,937,110
|
||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
2017
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
Managed care
|
$
|
-
|
$
|
367,357
|
$
|
-
|
$
|
1,813
|
$
|
-
|
$
|
2,589,987
|
$
|
16,659
|
$
|
2,218,270
|
$
|
-
|
$
|
354,917
|
$
|
2,589,987
|
||||||||||||||||||||||
Life insurance
|
182,010
|
45,518
|
339,507
|
8,751
|
-
|
161,846
|
24,819
|
87,348
|
18,511
|
61,372
|
161,846
|
|||||||||||||||||||||||||||||||||
Property and casualty insurance
|
18,778
|
694,444
|
-
|
75,785
|
-
|
77,225
|
9,489
|
50,761
|
23,595
|
18,392
|
81,520
|
|||||||||||||||||||||||||||||||||
Other non-reportable segments, parent company operations and net consolidating entries.
|
-
|
(443
|
)
|
-
|
-
|
-
|
(2,126
|
)
|
648
|
(3,278
|
)
|
-
|
426
|
(2,126
|
)
|
|||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
Total
|
$
|
200,788
|
$
|
1,106,876
|
$
|
339,507
|
$
|
86,349
|
$
|
-
|
$
|
2,826,932
|
$
|
51,615
|
$
|
2,353,101
|
$
|
42,106
|
$
|
435,107
|
$
|
2,831,227
|
|
Gross
Amount (1)
|
Ceded to
Other
Companies
|
Assumed
from Other
Companies
|
Net
Amount
|
Percentage
of Amount
Assumed
to Net
|
|||||||||||||||
|
||||||||||||||||||||
2019
|
||||||||||||||||||||
|
||||||||||||||||||||
Life insurance in force
|
$
|
9,739,154
|
$
|
9,739,154
|
0.0
|
%
|
||||||||||||||
|
||||||||||||||||||||
Premiums:
|
||||||||||||||||||||
Life insurance
|
$
|
186,489
|
$
|
8,337
|
$
|
2,052
|
$
|
180,204
|
1.1
|
%
|
||||||||||
Accident and health insurance
|
2,989,550
|
4,296
|
346
|
2,985,600
|
0.0
|
%
|
||||||||||||||
Property and casualty insurance
|
140,763
|
53,687
|
-
|
87,076
|
0.0
|
%
|
||||||||||||||
Total premiums
|
$
|
3,316,802
|
$
|
66,320
|
$
|
2,398
|
$
|
3,252,880
|
0.1
|
%
|
||||||||||
|
||||||||||||||||||||
2018
|
||||||||||||||||||||
|
||||||||||||||||||||
Life insurance in force
|
$
|
9,158,253
|
$
|
9,158,253
|
0.0
|
%
|
||||||||||||||
|
||||||||||||||||||||
Premiums:
|
||||||||||||||||||||
Life insurance
|
$
|
174,624
|
$
|
8,780
|
$
|
2,044
|
$
|
167,888
|
1.2
|
%
|
||||||||||
Accident and health insurance
|
2,691,289
|
3,824
|
308
|
2,687,773
|
0.0
|
%
|
||||||||||||||
Property and casualty insurance
|
143,917
|
60,987
|
-
|
82,930
|
0.0
|
%
|
||||||||||||||
Total premiums
|
$
|
3,009,830
|
$
|
73,591
|
$
|
2,352
|
$
|
2,938,591
|
0.1
|
%
|
||||||||||
|
||||||||||||||||||||
2017
|
||||||||||||||||||||
|
||||||||||||||||||||
Life insurance in force
|
$
|
10,307,506
|
$
|
10,307,506
|
0.0
|
%
|
||||||||||||||
|
||||||||||||||||||||
Premiums:
|
||||||||||||||||||||
Life insurance
|
$
|
166,280
|
$
|
8,826
|
$
|
4,174
|
$
|
161,628
|
2.6
|
%
|
||||||||||
Accident and health insurance
|
2,591,796
|
3,392
|
288
|
2,588,692
|
0.0
|
%
|
||||||||||||||
Property and casualty insurance
|
135,689
|
59,077
|
-
|
76,612
|
0.0
|
%
|
||||||||||||||
Total premiums
|
$
|
2,893,765
|
$
|
71,295
|
$
|
4,462
|
$
|
2,826,932
|
0.2
|
%
|
(1) |
Gross premiums amount is presented net of intercompany eliminations of $4,466, $2,590 and $2,126 for the years ended December 31, 2019, 2018, and 2017, respectively.
|
|
Additions
|
|||||||||||||||||||
|
Balance at
Beginning of
Period
|
Charged to
Costs and
Expenses
|
Charged (Reversal)
To Other Accounts
- Describe (1)
|
Deductions -
Describe (2)
|
Balance at
End of
Period
|
|||||||||||||||
|
||||||||||||||||||||
2019
|
||||||||||||||||||||
|
||||||||||||||||||||
Allowance for doubtful receivables
|
$
|
42,042
|
17,539
|
1,360
|
(4,396
|
)
|
$
|
56,545
|
||||||||||||
|
||||||||||||||||||||
2018
|
||||||||||||||||||||
|
||||||||||||||||||||
Allowance for doubtful receivables
|
$
|
35,883
|
4,754
|
6,569
|
(5,164
|
)
|
$
|
42,042
|
||||||||||||
|
||||||||||||||||||||
2017
|
||||||||||||||||||||
|
||||||||||||||||||||
Allowance for doubtful receivables
|
$
|
37,307
|
5,210
|
(3,748
|
)
|
(2,886
|
)
|
$
|
35,883
|
(1) |
Represents premiums adjustment to provide for unresolved reconciliation items with the Government of Puerto Rico and other entities.
|
(2) |
Deductions represent the write-off of accounts deemed uncollectible.
|
|
As of December 31,
|
For the Years Ended December 31,
|
||||||||||||||||||||||||||||||||||||||
Year
|
Deferred
Policy
Acquisition
Costs
|
Reserve for
Unpaid Claims
and Claims
Adjustment
Expenses
|
Unearned
Premiums
|
Earned
Premiums
|
Net
Investment
Income
|
Claims and Claim Adjustment
Expenses Incurred
Related to
|
Amortization of
Deferred Policy
Acquisition
Costs
|
Paid Claims and
Claim Adjustment
Expenses
|
Premiums
Written
|
|||||||||||||||||||||||||||||||
Current
Year
|
Prior
Years
|
|||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
2019
|
$
|
22,434
|
$
|
322,018
|
$
|
80,224
|
$
|
87,689
|
$
|
9,773
|
$
|
43,589
|
$
|
(4,041
|
)
|
$
|
22,742
|
$
|
36,467
|
$
|
150,519
|
|||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
2018
|
$
|
17,019
|
$
|
496,876
|
$
|
71,082
|
$
|
83,543
|
$
|
10,800
|
$
|
40,619
|
$
|
119,323
|
$
|
25,756
|
$
|
40,158
|
$
|
139,826
|
||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
2017
|
$
|
18,778
|
$
|
694,444
|
$
|
75,785
|
$
|
77,225
|
$
|
9,489
|
$
|
60,696
|
$
|
(9,935
|
)
|
$
|
23,595
|
$
|
47,689
|
$
|
143,787
|
I.
|
AMENDMENTS
|
|
1. |
Current Attachment 11 of the Contract shall be replaced in its entirety by a new Attachment 11 as set forth in Exhibit A to this Amendment. Attachment 11-A remains unchanged.
|
|
2. |
A new Section 22.1.1.1 shall be added:
|
|
1. |
For the rating period beginning November 1, 2019 and ending June 30, 2020, the GHP (Vital) PMPM Premium Rates included in Attachment 11 will be updated retroactively for the change in morbidity from the base period used for rate
development to the rating period. The change in morbidity, for each rate cell, will be calculated by comparing the risk score based on claims incurred November 2016 – April 2017 (paid through July 2017) to the risk score based on claims
incurred November 2019 – April 2020 (paid through July 2020) using CDPS v6.3+Rx.
|
|
(1) |
Notwithstanding the foregoing, because Updated PMPM Payment Rates are subject to CMS and FOMB approval, ASES will continue to pay Contractor at the PMPM Payment rates that existed prior to the Amendment Effective Date until such time
as the Updated PMPM Payment Rates have been approved by CMS and the FOMB; and
|
|
(2) |
Within thirty (30) calendar days following CMS and FOMB approval of Updated PMPM Payment Rates, the parties shall begin to reconcile any difference between (i) PMPM Payments that ASES made to Contractor after November 1, 2019, and
(ii) Updated PMPM Payment Rates.
|
ADMINISTRACIÓN DE SEGUROS DE SALUD DE PUERTO RICO (ASES)
|
||
/s/ Yolanda Garcia Lugo
|
11-15-2019
|
|
EIN: 66-05000678
|
Date
|
|
TRIPLE-S SALUD, INC.
|
||
/s/ Ms. Madeline Hernández Urquiza | 11-15-2019 | |
Ms. Madeline Hernández Urquiza, President
|
Date
|
|
EIN: 66-0555677
|
||
Account No. 256-5325 to 5330
|
Rate Cell
|
PMPM | ||||
Medicaid Pulmonary
|
$
|
216.74
|
|||
Medicaid Diabetes/Low Cardio
|
$
|
345.14
|
|||
Medicaid High Cardio
|
$
|
753.97
|
|||
Medicaid Renal
|
$
|
1,552.27
|
|||
Medicaid Cancer
|
$
|
1,847.48
|
|||
Medicaid Male 45+
|
$
|
129.43
|
|||
Medicaid Male 19-44
|
$
|
93.37
|
|||
Medicaid Male 14-18
|
$
|
79.80
|
|||
Medicaid Female 45+
|
$
|
169.85
|
|||
Medicaid Female 19-44
|
$
|
116.15
|
|||
Medicaid Female 14-18
|
$
|
89.27
|
|||
Medicaid Age 7-13
|
$
|
81.68
|
|||
Medicaid Age 1-6
|
$
|
91.26
|
|||
Medicaid Under 1
|
$
|
251.79
|
|||
Commonwealth Pulmonary
|
$
|
147.47
|
|||
Commonwealth Diabetes/Low Cardio
|
$
|
183.03
|
|||
Commonwealth High Cardio
|
$
|
404.40
|
|||
Commonwealth Renal
|
$
|
626.39
|
|||
Commonwealth Cancer
|
$
|
1,350.69
|
|||
Commonwealth Male 45+
|
$
|
71.54
|
|||
Commonwealth Male 19-44
|
$
|
50.92
|
|||
Commonwealth Male 14-18
|
$
|
48.57
|
|||
Commonwealth Female 45+
|
$
|
98.72
|
|||
Commonwealth Female 19-44
|
$
|
80.86
|
|||
Commonwealth Female 14-18
|
$
|
58.80
|
|||
Commonwealth Age 7-13
|
$
|
65.19
|
|||
Commonwealth Age 1-6
|
$
|
74.12
|
|||
Commonwealth Under 1
|
$
|
265.59
|
|||
CHIP Pulmonary
|
$
|
195.17
|
|||
CHIP Diabetes
|
$
|
536.72
|
|||
CHIP Age 7-13
|
$
|
72.98
|
|||
CHIP Age 14+
|
$
|
66.67
|
|||
CHIP Age 1-6
|
$
|
93.68
|
|||
CHIP Under 1
|
$
|
260.73
|
|||
Dual Eligible Part A and B
|
$
|
829.44
|
|||
Dual Eligible Part A Only
|
$
|
331.24
|
|||
Maternity Delivery Kick Payment
|
$
|
4,641.59
|
Rate Cell
|
PMPM Premium Rate
|
||||
Law 72, Article VI Public Employees and Pensioners*
|
$
|
180.00
|
•
|
To promote the honest and ethical conduct of our Financial Managers and Supervisors (described below), including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
|
•
|
To promote full, fair, accurate, timely and understandable disclosure in periodic reports and documents filed or submitted by the Corporation to the Securities and Exchange Commission (“SEC”) and in other public communications made by
the Corporation;
|
•
|
To promote compliance with all applicable laws, rules and regulations that apply to the Corporation and its officers;
|
•
|
To encourage the prompt internal reporting of violations of this Code; and
|
•
|
To provide accountability for adherence to this Code.
|
•
|
Encourage professional honesty and integrity in all aspects of the financial departments, by eliminating inhibitions and barriers to responsible behavior, such as coercion, fear of reprisal, or alienation from the financial departments
or the Corporation itself.
|
•
|
Prohibit and eliminate the appearance or occurrence of conflicts between what is in the best interest of the Corporation and what could result in material personal gain for a member of the financial departments, including Financial
Managers and Supervisors, or any other party.
|
•
|
Promptly bring to the attention of his/her supervisor, Human Resources, the Compliance Office, the Legal Affairs Office, the Internal Audit Office, the Disclosure Committee, the Audit Committee, or through Ethics Point, as appropriate,
any information he or she may have concerning (a) significant deficiencies in the design or operation of internal controls which could adversely affect the Corporation’s ability to record, process, summarize and report financial data or
(b) any suspicious behavior or apparent fraud, whether or not material, that involves employees who have a significant role in the Corporation’s financial reporting, disclosures or internal controls or (c) any information concerning
evidence of a material violation of the securities or other laws, rules or regulations applicable to the Corporation or (d) any deviations in practice from policies and procedures governing honest and ethical behavior.
|
•
|
Demonstrate their personal support for policies and procedures through periodic communication reinforcing these ethical standards throughout the finance departments.
|
•
|
The Corporation’s accounting records, as well as reports produced from those records, must be kept and presented in accordance with Generally Accepted Accounting Principles and any other principles as required, from time to time, by
law or regulatory agencies.
|
•
|
All records must fairly and accurately reflect the transactions or occurrences to which they relate.
|
•
|
All records must fairly and accurately reflect the Corporation’s assets, liabilities, revenues and expenses.
|
•
|
The Corporation’s accounting records must not contain any false or intentionally misleading entries.
|
•
|
No transaction may be intentionally misclassified as to accounts, departments or accounting periods or in any other manner.
|
•
|
All transactions must be supported by accurate documentation in reasonable detail and recorded in the proper account and in the proper accounting period.
|
•
|
No information may be concealed from the internal auditors or the independent external auditors.
|
•
|
Financial officers shall not knowingly or recklessly misrepresent material facts or allow their independent judgment to be compromised.
|
•
|
To issue or reissue a report on the Corporation’s financial statements that is not warranted under the circumstances, due to material violations of Generally Accepted Accounting Principles, Generally Accepted Auditing Standards or
other professional or regulatory standards;
|
•
|
Not to perform an audit, review or other procedure required by Generally Accepted Auditing Standards or other professional or regulatory standards;
|
•
|
Not to withdraw an issued report; or
|
•
|
Not to communicate matters to the Corporation’s Audit Committee.
|
•
|
Educate members of the finance departments about any federal, state, or local statute, regulation, or administrative procedure that affects the operation of the finance departments and the Corporation.
|
•
|
Monitor the compliance of the finance departments with any applicable federal, state, or local statute, regulation, or administrative rule.
|
•
|
Identify, report, and correct in a swift and certain manner, any detected deviations from applicable federal, state, or local statute, regulation or administrative procedure.
|
Received by:
|
|
|
|
Name |
|
|
Signature |
|
|
Date
|
|
• |
Triple-S Salud, Inc. (“TSS”), a wholly-owned subsidiary of TSM.
|
|
o |
Triple-S Advantage, Inc. (“TSA”), a wholly-owned subsidiary of TSS.
|
• |
Triple-S Vida, Inc., a wholly-owned subsidiary of TSM.
|
• |
Triple-S Propiedad, Inc., a wholly-owned subsidiary of TSM.
|
1. |
I have reviewed this Annual Report on Form 10-K of Triple-S Management Corporation (“the registrant”);
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4. |
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
c. |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
d. |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has
materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5. |
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
|
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect
the registrant’s ability to record, process, summarize and report financial information; and
|
|
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
February 28, 2020
|
By:
|
/s/ Roberto
García-Rodríguez
|
|
Roberto García-Rodríguez
|
||||
President and Chief Executive Officer
|
1. |
I have reviewed this Annual Report on Form 10-K of Triple-S Management Corporation (“the registrant”);
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4. |
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
c. |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
d. |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has
materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5. |
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors
and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
|
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the
registrant’s ability to record, process, summarize and report financial information; and
|
|
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
February 28, 2020
|
By:
|
/s/ Juan J.
Román-Jiménez
|
|
Juan J. Román-Jiménez
|
||||
Executive Vice President and Chief Financial Officer
|
|
a) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
b) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
February 28, 2020
|
By:
|
/s/ Roberto
García-Rodríguez
|
|
Roberto García-Rodríguez
|
||||
President and Chief Executive Officer
|
|
a) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
b) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
February 28, 2020
|
By:
|
/s/ Juan J.
Román-Jiménez
|
|
Juan J. Román-Jiménez
|
||||
Executive Vice President and Chief Financial Officer
|